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iAbstract
Vertical-external-cavity surface-emitting lasers (VECSELs) are versatile lasers sources that have
become particularly appealing for different applications due to the unique features they can offer.
They combine the wide wavelength coverage of semiconductor laser technology with the good
beam quality and power scalability of solid-state thin-disk lasers. The external cavity architectures
also allow for efficient frequency conversion from infrared to visible and UV wavelengths. In this
way, VECSELs can provide high-power emission with good beam quality at the most challenging
wavelengths, such as the yellow spectral region. Moreover, one of their major benefits is the
compact design, which is particularly important for applications.
Potential applications for VECSELs are manifold and include fields such as medicine, astronomy
and quantum optics research. This thesis is concerned with the medical applications, and
particularly focuses on dermatologic applications requiring yellow lasers. The yellow spectral
range is challenging for any laser technology, which is why not that many yellow lasers exist on
the laser market. The first main objective of this thesis was to demonstrate frequency converted
yellow-orange-red VECSELs in laboratory set-ups. This was followed by the development of a fully
functional yellow laser based on VECSEL-technology and designed for medical use. Finally, the
work was focused on performing a clinical trial designed to test the feasibility of
VECSEL-technology in a dermatologic medical application.
As a result of this thesis work, we have demonstrated record high output powers from laboratory-
based VECSELs: 20 W at 585 nm, 10 W at 615 nm and 72 W at 1180 nm. Moreover, the performed
clinical trial showed that the developed yellow VECSEL system is at least as good as the
traditionally used laser in the treatment of vascular lesions (specifically telangiectasia) in terms of
the treatment efficacy. In addition, the treatment times were significantly shorter with the VECSEL
system than with the traditional laser thanks to the fast scanning of the light application device.
ii
With further improvements arising from the full exploitation of the laser’s power reserve, the system
has the potential to be a breakthrough in the treatment of vascular-related skin conditions.
iii
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Introduction
 Background and motivation
Lasers have been an important tool for many research, medical and industry fields since the first
Ruby laser was constructed by T. H. Maiman in 1960. During the last six decades, several laser
technologies have emerged and developed providing solutions for a variety of problems. Currently,
the most common laser type is an electrically pumped semiconductor laser, also known as a laser
diode (LD). They have a small footprint, low power consumption and a broad wavelength coverage
and can be found in many devices such as DVD players and laser printers. However, they suffer
from poor beam quality due to the slit geometry of the output surface, which leads to a large beam
divergence. Moreover, the output power from a single laser diode is typically limited to some
hundreds of milliwatts, though several can be stacked to reach multi-watt operation at the expense
of the output beam quality.
Other laser technologies also include solid state, dye/gas and fibre lasers. They all have their
advantages and disadvantages. Fibre lasers are known for high-power and easy delivery of light
through the fibre, but are limited in the range of wavelengths. In turn, solid state lasers are mature
and reliable, but the wavelength coverage is strictly limited to the ion transitions of the lasing
material; they are also bulkier and more complex than fibre lasers. Dye and gas lasers were one
of the first type lasers (along with solid state) to arrive in the market providing high-power
continuous wave or pulsed laser light, but in addition to being complex they are also restricted in
the wavelength coverage due to ion transition.
Overall, all the different laser technologies can offer a “colourful spectrum” of features and effective
solutions for applications but (ironically) there appears to be a common challenge: high-power,
short-pulse or continuous wave operation is achievable, but often at the expense of the spectral
properties such as the emission wavelength. This is particularly true at the visible wavelength
Chapter 1. Introduction
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range, which also is relevant for many applications in biophotonics. Moreover, laser development
in general has always been largely driven by applications. So far, lasers have vastly penetrated
industry, medicine, scientific research, military and entertainment. With such large variety of
applications, it is practically impossible to develop an all-purpose laser system, which is why
customizability has become an important feature for lasers. Different applications set quite
different requirements for the light source in terms of size, operation mode, power and spectral
features. For example, quantum optics research relies on the availability of narrow linewidth,
resonantly tuned lasers to interrogate or change the state of atoms. Whereas, high-power yellow
lasers emitting light pulses in the millisecond order are needed in dermatology to treat certain skin
diseases. To this end, the work presented in this thesis focuses on developing a particular
type of semiconductor laser, which could bridge the gaps in the emission wavelength
coverage of lasers, provide customised solutions for a variety of applications, and even
enable the emergence of new applications.
This type of semiconductor lasers, called vertical-external-cavity surface-emitting lasers
(VECSELs) or Semiconductor Disk Lasers (SDLs), are recognized for their power scaling abilities,
excellent beam quality, compact footprint and customizable spectral features. They combine the
most beneficial characteristics of standard semiconductor and solid-state lasers: wavelength
tailoring through material engineering and functionality enabled by external cavity architectures.
These features allow for a broad coverage of lasing wavelengths in the infrared and, via second
harmonic generation in nonlinear crystals, in the visible and UV spectral ranges [1]. Table 1.1
presents how VECSELs compare to other laser technologies in terms of general properties such
as emission wavelength, output power, operation scheme etc.
1.1    Background and motivation
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Table 1.1. List of main type of lasers and their general properties
Laser
type
Gain medium Wavelength
coverage
Power level Beam
quality
Operation
schemes
Size
Solid-
state
lasers
Crystals
(Nd:YAG,
Ruby)
Limited (ion
transitions)
Peak power
in  kW range
Good-
excellent
CW and
pulsed (down
to fs)
Complex
and bulky.
Fibre
lasers
Optical fibre
(Erbium,
Ytterbium)
Limited Peak power
up to kW
range
Good-
excellent
CW and
pulsed
Compact
to large
Gas
lasers
Gas (CO2,
Excimer,
Copper
vapour,
Argon-ion)
Limited Peak power
in kW range
Good-
excellent
Operate in
pulsed mode
(ns...ms)
Complex
and bulky
Dye
lasers
Dye
(Rhodamine,
Fluorescein)
Relatively
broad, but
limited
Up to kW
range
Poor-
good
Typically
pulsed (ns),
also CW
Complex
and bulky
Laser
diodes
Semiconductor
material
Broad < 10 W from
single diode.
> 100 W
from stacked
diodes
Poor CW and
pulsed
Compact
VCSELS Semiconductor
material
Narrow
(DBR
limited)
1–10 mW Excellent CW and
pulsed
Compact
VECSELS Semiconductor
material
Very broad
(efficient
SHG)
< 100 W Good-
excellent
CW and pulse
operation from
ms down to fs
Compact
The development of the VECSELs in this thesis was mainly driven by medical applications. In fact,
lasers and medical applications have a long history: only a year after the first demonstration of
laser light (1960), a ruby laser was used to treat retinal lesions in rabbits [2], and in the past years,
lasers have become important tools in many areas of healthcare and life sciences. Figure 1.1
illustrates the power and wavelength needs of different medical and life science applications. Apart
from laser surgery, many applications fall on the visible spectral range. There already exists
practical techniques to produce blue, green and red laser light, but the yellow-orange spectral
range has proven to be challenging due to material restrictions. The golden standard for current
Chapter 1. Introduction
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medical treatments requiring a yellow light source is the pulsed dye laser (PDL, for instance
Candela V-Beam), which is known for its long wavelength (585–590 nm), adjustable pulse duration
and integrated skin cooling for patient comfort and selective skin damage. However, it also has
major disadvantages such as high initial cost, large size and circular beam profile. In addition, PDL
lasers require annual maintenance to change the dye even if the laser has not been used, which
is an added cost. For this reason there is still a need for a more compact, cost-effective and tailored
yellow laser, which in the long run could increase the availability of yellow laser treatments and
lower their cost for patients. Moreover, the availability of yellow-orange lasers with tailored or
tunable wavelengths could also spark new application avenues that have been undiscovered so
far due to the lack of available wavelengths in practical systems. Currently, the main medical
applications for yellow lasers include eye surgery, dermatology and cell imaging, and it has already
been shown that overall results can be improved and damage to healthy tissue decreased if lasers
with tailored specifications are employed [3, 4, 5].
Figure 1.1. Illustration of the laser wavelength and output power requirements for medical and
other life science applications.
In addition to medical applications, we also took into consideration other application areas that
could benefit from high-power operation in the yellow-orange spectral region or from other visible
and UV wavelengths that could be reach with similar frequency-doubling techniques as employed
in this thesis to reach the yellow spectral range. For example, in astronomy, adaptive optics is
often employed on earth-based telescopes to correct for the distortion of images caused by the
1.2    Objectives
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variations in the index of refraction of air. As part of the adaptive optics system, a reference
object—a so-called guide star—is needed [6]. Unfortunately, there are not many naturally
occurring guide stars in the sky, but one can be created artificially by exciting sodium atoms at
~80 km altitude with a yellow laser. The wavelength needs to match the sodium D2 line and emit
high-power radiation. In terms of laser specifications, this means over 20 W of continuous wave
radiation at the challenging yellow wavelength of 589 nm with a narrow linewidth less than
250 MHz [7]. So far, these specifications have been matched only by expensive Raman fibre
amplifier lasers employing single-frequency diode seed lasers [8].
Another field, which could benefit from tailored high-power VECSELs is quantum optics research.
It has opened doors to ultra-fast computing, high bandwidth information transfer and other
applications requiring precise knowledge of time or frequency. These developments rely on the
manipulation of single quantum systems enabled by laser cooling of trapped atoms, first
demonstrated by David Wineland in 1978 [9]. Furthermore, they could result in practical quantum
optical devices such as atomic magnetometers, atomic clocks and, of course, a scalable quantum
computer capable of solving problems not feasible for a classical computer [10, 11, 12]. These
exciting developments depend on the availability of narrow-linewidth high-intensity lasers emitting
at specific wavelengths in order to control quantum states. Narrow linewidth is essential, because
the atoms need to be excited resonantly and the required wavelength is strictly determined by the
atom in question. Quite often, the required wavelength is in the ultraviolet range, which can be
achieved with VECSELs by first developing a visible laser and then frequency converting it to UV.
In fact, this type of red VECSEL was used in manipulation of trapped magnesium ions by Burd et
al. in 2016 [13].
 Objectives
The general objective of the thesis was to develop VECSELs at challenging yellow-orange and
red wavelengths where a high benefit could be expected in medical applications. This was
achieved by first determining the prospective applications for yellow-orange lasers in medicine.
Moreover, we also wanted to demonstrate the full development trajectory of a laser, from
laboratory setup to a functional laser system, and perform a proof-of-concept clinical trial to
validate the feasibility of using VECSELs in medical applications. The main objectives are listed in
Table 1.2.
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Table 1.2. List of the main objectives of this thesis.
1.  Identify prospective medical applications for yellow VECSELs.
2. Develop high-power frequency-doubled VECSELs in research environment.
3. Design and built a yellow VECSEL system for clinical use.
4. Design and perform a clinical trial using the yellow VECSEL system in
collaboration with local physicians.
 Outline
This thesis is organised into six chapters. Chapter 2 introduces the prospective medical
applications for VECSELs emitting yellow-orange radiation and generally explains the light-tissue
interaction related to dermatologic treatments. Chapter 3 is devoted to presenting VECSEL
technology including the operation principle and basic characteristics. This chapter will explain the
benefits of the external cavity and the wavelength coverage enabled by material engineering.
Particular emphasis is put on frequency-doubled VECSELs and on the choice of nonlinear crystal.
Chapter 4 reports the lasing features of the developed VECSELs and is divided into three sections,
which present a high-power yellow, red and infrared VECSEL. These results correspond to
publications P1, P2 and P3, respectively. This chapter also demonstrates a pulsing scheme for
VECSELs, which is based on modulating the current of the pump laser. Chapter 5 discusses the
needs for organizing a clinical trial for a research device. It will list all the mandatory preparations
and documentations, as well as give an idea of the time schedule. Section 5.2 reports the technical
specifications and other features of the developed yellow laser system. The end of chapter 5 is
devoted to explaining the clinical protocol and the clinical results. It will include comments from the
dermatologists on the usability and reliability of the yellow laser.
Chapter 6 concludes this thesis with a short summary of the laser results and the outcome of the
clinical trial. The final words will give an outlook on the future of frequency converted VECSELs.
2.1    Basic concepts of laser-tissue interaction
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2 Medical Applications for Yellow Lasers
Chapter 2
Medical Applications for yellow
lasers
This chapter reviews the basic laser-tissue interactions in section 2.1 and focuses on discussing
the interaction most relevant for yellow lasers—selective photothermolysis—in section 2.2. Yellow
lasers are mainly required by dermatology for the treatment of superficial blood vessels and thus
the section 2.2 also identifies the ideal laser parameters for this treatment method. The chapter is
concluded with a short review on the already existing commercial yellow lasers with their
drawbacks that emphasise the need for more tailored lasers.
 Basic concepts of laser-tissue interaction
The interaction of laser light with biological tissue is depended on the specific properties of the
laser light and the targeted tissue. The main affecting properties of the laser light are wavelength,
irradiance, power/energy and for pulsed irradiation pulse duration, energy per pulse and repetition
rate. On the tissue side, these are the optical properties, heat transport and chemical composition,
particularly the composition of the absorption molecules—so-called chromophores. The
combination of these properties result in tissue specific reactions that are mainly based on the
absorption of photons. To put it simply, when laser light enters tissue it is either absorbed or not.
If it is not absorbed it can experience reflection, refraction, scattering, remission and/or
transmission (as illustrated in Figure 2.1.), but these phenomena play less important roles in
medical laser treatments based on the thermal effect (i.e. heat) induced by the absorption of
photons [14, 15, 16]. Moreover, particular emphasis should be given to the wavelength of the
Chapter 2. Medical Applications for Yellow Lasers
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incident laser, because many of the optical properties of tissue (such as absorption coefficient and
scattering coefficient) show wavelength dependence [17].
Figure 2.1. Illustration of the phenomena that happen when light encounters biological tissue (or
any media): reflection, remission, refraction, absorption, scattering, transmission.
Figure 2.2. Wavelength dependence of absorption coefficient for some of the main tissue
components: water, melanin (14.26 mg/ml concentration) and haemoglobin. The figure was
constructed using data from [18, 19, 20].
2.1    Basic concepts of laser-tissue interaction
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The wavelength dependence of the absorption coefficients for some of the main tissue
chromophores are given in Figure 2.2. The figure clearly shows water as the dominant absorber
in the infrared range with the maximum water absorption at around 3 µm. In contrast, the visible
spectral range from 400–800 nm is identified by minimal absorption by water and, instead,
dominant absorption by melanin and two types of haemoglobin. Furthermore, if we also consider
the wavelength dependence of the scattering coefficients of these chromophores we can estimate
the wavelength dependent optical penetration depth. This estimation is based on the
Beer-Lambert Law, which defines that the attenuation coefficient is a combination of the absorption
and scattering coefficients. The optical penetration depth in tissue as a function of wavelength is
presented in Figure 2.3. Although the spatial distribution of light induced heat is related to the
optical penetration depth, there is also heat dissipation due to heat diffusion and heat transport by
perfusion. The so-called thermal heat reach depends on the thermal conductivity of the tissue and
the exposure time of the applied light. Table 2.1 lists some values of the thermal heat reach for
typical exposure times. Thus the optical penetration depth and thermal heat reach define the
spread of the laser induced tissue reaction. In case of short or pulsed laser exposure of the tissue
the thermal reach is low compared to the optical penetration depth [21, 22, 23, 24].
Figure 2.3. Wavelength dependence of optical penetration depth in tissue. Courtesy of Dr.
Ronald Sroka.
Table 2.1. Some values of thermal heat reach in tissue for certain exposure times. A mean thermal
conductivity of 1.2 x 10-7 m2/s was used.
Exposure time Thermal heat reach
10 s 2.3 mm
1 s 0.7 mm
1 ms 23 µm
1 µs 0.7 µm
Chapter 2. Medical Applications for Yellow Lasers
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 Laser induced tissue reactions
The laser induced tissue reactions are plentiful, but can be divided into five main categories. These
are photochemical interactions, thermal interactions, photoablation, plasma-induced ablation and
photodisruption. The first three categories exhibit wavelength dependence and all, apart from the
photochemical reactions, occur due to the absorbed laser light being transferred into heat. Figure
2.4 depicts how these reactions are related to the irradiance (y-axis) and the exposure time (x-axis)
of the laser light. Following the diagonal drawn in the figure, we can see that the total energy
density (fluence, J/cm2) is within the same orders of magnitude for all the mechanisms. This
indicates that the exposure time is the main defining parameter for a type of interaction [17]. Short
definitions for each tissue reaction are provided in Table 2.3 along with their sub-types, some
examples of clinical applications and typically used lasers. This thesis focuses on the thermal
interactions and one particular sub-type of it, namely coagulation.
Figure 2.4. Laser-tissue interaction map. The double-logarithmic graph shows irradiance on the
y-axis and exposure time on the x-axis. The four diagonal lines represent lines of constant fluence.
Each coloured circle represents a type of mechanism and gives a rough estimate of the associated
laser parameters. Adapted from [17] and [25].
Coagulation is defined as the denaturation of proteins, which occurs at temperatures around 60–
65 °C. Optically the scattering coefficient increases thus more light is back-scattered from the
tissue surface. Dependent on the surrounding chromophores, whitening or scattering induced
colour change can be observed. The coagulation process is often used to occlude (close) vessel
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structures during the laser treatment of vascular lesions (vascular = relating to blood vessels). In
this case, the spread of the laser induced reaction correlates more with the thermal heat reach
than with the optical penetration thickness due to the relative low penetration depth. Further
increase of the temperature results in drying of the tissue as water starts to vaporise around 100 °C.
This results in a reduction of the thermal conductivity of the tissue. Higher temperatures (150–
300 °C) lead to burning and carbonisation. In this case the absorption coefficient increases and
the tissue becomes black. All the light is then absorbed in this black area, hence there is no optical
penetration, only heat diffusion into the tissue. At temperatures above 300 °C (can be reached by
e.g. contact of fibre to the tissue) tissue is instantaneously vaporised and ablated. This process is
useful for cutting tissue especially when bloodless incisions are of clinical interest. Furthermore,
high-energy laser pulses can lead to plasma formation (e.g. ionisation), cavitation bubble induction
and shockwaves which are used for destruction of hard tissue (e.g. kidney stone). The temperature
induced reactions and their influence on the physical properties of tissue are listed in Table 2.2
[21, 22, 23, 24].
Table 2.2. Temperature induced reactions in tissue.
Temperature Reaction Optical/mechanical
change
> 40 °C Enzyme reaction, edema (swelling),
membrane loosening
45–65 °C Tissue changes (reversible/irreversible
depending on duration)
> 65 °C Coagulation, protein denaturation Scattering
coefficient increase
> 100 °C Drying (water vaporisation) Thermal conductivity
decrease
> 150 °C Carbonisation Absorption
coefficient increase
> 300 °C Vaporisation, ablation, burn Removal
 1000 °C Ionisation, plasma Shockwave
As can be derived from Table 2.2, several of the described thermal reactions can be present in
parallel and influence each other because of the induced changes in the physical properties of the
tissue. However, in a specific application most often only one effect is wanted, which puts even
more emphasis on the importance of choosing the right laser parameters. The next section
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explains how coagulation is utilized in the dermatologic treatment concept called selective
photothermolysis, and what is required from the laser source, particularly in terms of wavelength
and pulse duration.
Table 2.3. List of laser-tissue interaction mechanisms. Data for the table was collected from [17]
and [25], which also provide more detailed descriptions of the mechanisms.
Photochemical
Description Sub-types Applications
Light induces chemical reactions in
tissue.
Pulse duration:
1 s…CW
Power density:
0.01–50 W/cm2
Typical lasers:
Red diode lasers, other visible
lasers, also incoherent light
sources
Photodynamic therapy (PDT):
administered photosensitizers
(chromophores that cause light-induced
reactions) are excited with light, inducing a
reaction that creates reactive oxygen
species or singlet oxygen which
themselves induce cell death via different
pathways.
Biomodulation: energy of absorbed
photons may affect cellular metabolism by
inducing stimulative or inhibitive effects.
Though, these effects are still under
investigation.
Cancer treatment,
wound healing,
acupuncture
Thermal
Description Sub-types Applications
Absorbed light generates heat. The
temperature increase causes
different effects on tissue depending
on the duration and achieved peak
temperature.
Pulse duration:
1 µs…1 min
Power density:
10–106 W/cm2
Typical lasers:
Visible and IR lasers (KTP, Argon,
PDL, diode lasers, CO2, Nd:YAG,
Er:YAG)
Coagulation: tissue that reaches 60–65 °C
starts to coagulate (protein denaturation,
blood clotting) and a change in colour can
be observed.
Vaporisation: around 100 °C, water in
tissue vaporises creating pressure that
leads to microexplosions.
Carbonization: at higher temperatures than
100 °C, tissue starts to release carbon and
blackens.
Vessel treatment,
eye-vessel closure,
endovenous laser
treatment, laser-
induced interstitial
thermotherapy,
laser incision with
sealing of the small
vessels
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Photoablation
Description Applications
“Etching” of tissue with minimal thermal damage. High-energy photons directly
break molecular bonds causing ablation.
Pulse duration:
10…100 ns
Power density:
107–1010 W/cm2
Typical lasers:
Excimer lasers, fs-lasers
Offers precise and
clean “cutting” and,
hence, is used in
refractive corneal
surgery, cutting
without sealing
Plasma-induced ablation
Description Applications
Also known as plasma-mediated ablation. Part of a phenomenon called optical
breakdown. High-energy light pulses ionize molecules in tissue. The created
plasma bubble ablates tissue with negligible thermal effects. This mechanism also
neglects secondary effects of plasma, which are included in the next mechanism.
Pulse duration:
100 fs…500 ps
Power density:
1011–1013 W/cm2
Typical lasers:
Nd:YAG, Ti:Sapphire, fs-lasers
Refractive corneal
surgery, dental
caries removal,
neurovascular
studies [26]
Photodisruption
Description Applications
In addition to plasma formation, also shock waves are generated as part of the
optical breakdown phenomena. In tissue, this can also lead to cavitation and jet
formation. These phenomena cause mechanical forces that “rupture” or “cut”
tissue.
Typical pulse duration:
100 fs…1 ms
Typical power density:
1011–1016 W/cm2
Typical lasers:
Nd:YAG, Ti:Sapphire
Lens
fragmentation,
lithotripsy
(destruction of
kidney/gall stones)
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 Laser light treatment of cutaneous vascular
lesions
Lasers have been used in dermatology to treat cutaneous vascular lesions (unwanted superficial
blood vessels on the skin), such as telangiectasia, hemangiomas and naevus, for over three
decades. In fact, laser treatment of facial telangiectasia (dilated blood vessels) is one of the most
frequently requested laser treatments in dermatology. The current treatment modalities are based
on the technique of selective photothermolysis published by Anderson and Parrish in 1983 [27].
In the paper, they explain how microvessels—or indeed any other tissue target—can be selectively
targeted and thermal damage to the surrounding tissue minimized by choosing an appropriate
wavelength of light. In the treatment of vascular lesions, the aim is to destroy unwanted
microvessels by selectively targeting oxyhaemoglobin, a chromophore abundant in blood.
Oxyhaemoglobin absorbs the light energy (particularly that of 418, 542 and 577 nm as shown later)
and converts it to heat, which spreads to the rest of the vessel structure causing the desired
thermal damage [28] i.e. destruction of the vessel. At the same time, absorption by other main
chromophores in skin, most notably melanin and water, should be minimized in order to only target
the microvessels [29].
Figure 2.5 shows the absorptions curves for haemoglobin, melanin and water with emphasis
around the visible spectrum.  As indicated in the figure with arrows, oxyhaemoglobin has high
absorption peaks at 418, 542 and 577 nm. The absorption is highest around 418 nm, but this
region also has high absorption in melanin (dotted brown and orange curves) than the 542-nm
and 577-nm regions. Melanin absorption continues to decrease towards the longer wavelengths
of light, which makes longer yellow wavelengths, such as 585–590 nm, better suited for the
treatment of deeper vessels, as the laser light is absorbed less by the upper layers of the skin [30].
In fact, the absorption in different chromophores in different skin layers largely determine the
optical penetration depth of a laser wavelength (earlier shown in Figure 2.3). The wavelength
dependence of optical penetration depth is additionally illustrated in Figure 2.6 giving emphasis to
the currently commercially available laser wavelengths.
The main absorbers in the upper layer of skin (epidermis) are different types of melanin (eumelanin,
pheomelanin), which have increasing absorption towards the blue-green spectral range. For this
reason, blue-green laser light only penetrates some hundreds of micrometres into skin and is,
therefore, mainly good for the treatment of very superficial vessels. In the deeper layers of skin
(dermis), both types of haemoglobin as well as water start to play a larger role. Absorption of
haemoglobin is the dominant reason why longer visible wavelengths (such as yellow-orange-red)
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only reach optical penetration depth up to few millimetres. Although haemoglobin absorption
decreases for red and infrared wavelengths, the increasing absorption of water (which is present
in all layers of skin) from 600 nm onwards limits the overall practical penetration depth of lasers to
some millimetres. Deeper penetration can in principle be achieved with higher fluence, but it is
accompanied by the reduction of selective absorption and the increased risk of collateral damage
due to unspecific heating.
Figure 2.5. Absorption curves for the main skin constituents (melanin, haemoglobin and water) as
functions of wavelength. The figure was constructed using data from [18, 19, 20].
Figure 2.6. Wavelength dependence of the penetration depth of dermatologic lasers. Wavelengths
are indicated in nanometers on the top of the illustration.
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In addition to wavelength, the pulse duration of the laser light also needs to be optimised according
to the target chromophore. The determination of the appropriate pulse duration relies on the
concept of thermal relaxation time (TRT). TRT is the time needed for a chromophore to dissipate
half of its heat gained from the laser light, and ideally the pulse duration should match the TRT of
the chromophore. If the pulse is shorter than the TRT it might not produce enough heat for effective
treatment, whereas, very short pulses can cause vessel rupture that leads to visible purpura [31].
Laser pulses that are longer than the TRT produce excessive heat at the target resulting in
collateral damage on the surrounding tissue due to increased heat diffusion (see Table 2.1). TRT
is longer for larger vessels and, hence, longer pulse durations should be used for larger vessels.
As a rule of thumb, the pulse durations for 0.1–1 mm thick vessels should be in the range of 1–
100 ms [32].
In summary, microvessels can be destroyed with laser light through transfer of energy from light
into heat. Furthermore, the process can be made more selective by targeting only certain
chromophores (in this case haemoglobin) with a specific wavelength. In addition, the pulse
duration of the light should also be adjusted according to the vessel diameter. The wavelength
selection minimizes absorption by other chromophores and the correct pulse duration assures
effective treatment without subjecting the surrounding tissue to excessive heat. These two
concepts set the targets for the laser sources in dermatology. The high haemoglobin absorption
peak at 577 nm makes it a tempting choice for the treatment of cutaneous vascular lesions.
However, currently used yellow lasers, such as pulsed dye lasers (PDLs), have opted for a longer
wavelength of 585–590 nm in order to increase the penetration and decrease the melanin
absorption while still maintaining high haemoglobin absorption. In terms of fluence, the typical
values used in the treatment of vascular lesions by a yellow laser range between 5 and 20 J/cm2
[30].
 Existing laser systems for the treatment of
vascular lesions
Table 2.4 lists the currently commercially available lasers studied for treating vascular lesions, also
indicating their emission wavelength and pulse length [32, 33]. The current golden standard for
the treatment of vascular lesions is the pulsed dye laser (PDL, e.g. Cynergy Cynosure and
Candela Vbeam). It has been used to treat vascular lesions since 1985 and offers a versatile
solution for a variety of conditions [30]. The main features include a typical emission wavelength
of 585 or 595 nm, pulse durations in the 10–40 ms range and spot sizes ranging from 3 mm up to
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about 12 mm. In addition, a dynamic skin cooling device is often used in parallel to reduce
discomfort and to allow the use of higher fluence. Earlier versions of the PDL had a much shorter
pulse duration of ~0.45 ms but a longer pulse was later employed to reduce purpura and vessel
rupture. The PDL is the first laser that has been designed according to the theory of selective
photothermolysis and, therefore, is not associated with severe adverse effects [30]. However, the
drawbacks of the PDL system include large size and high acquisition and maintenance costs.
Furthermore, the system delivers the laser light in a circular beam pattern, which makes it difficult
to cover treatment areas uniformly.
Table 2.4. List of currently available commercial lasers for the treatment of vascular lesions [P4].
Laser Technology Wavelength (nm) Pulse length
(ms)
KTP Frequency-doubled solid-
state laser
532 1–200
Copper vapour Metal-vapour laser 578 50–200
Pulsed Dye Laser
(PDL)
Dye laser 585, 590, 595, 600 0.45–40
Alexandrite Solid-state laser 755 3
Diode Semiconductor laser 800, 810, 930 1–250
Nd:YAG Solid-state laser 1064 1–100
Other commercially available and traditional options for the treatment of vascular lesions include
the green-light emitting KTP laser and the yellow-light emitting copper bromide laser. The KTP
laser operates at 532 nm and, therefore, has a high absorption by melanin, which leads to an
increased risk of dyspigmentation [34]. The yellow copper bromide laser, on the other hand, is
commonly associated with adverse side effects, such as scarring and hypo- and
hyperpigmentation [35]. In the 1980s, the blue-green emitting argon laser (along with the red-light
emitting ruby laser) was the most frequently used laser to treat vascular lesions, but since then it
has been replaced with lasers emitting in the longer wavelength range. Lasers emitting beyond
the yellow spectral region, i.e. in the red and near-infrared, have also been considered due to their
ability to penetrate deeper in the skin. Such lasers (the red Alexandrite, diode lasers and Nd:YAG)
are used only to target large vessels, deeply located in the skin. In their case, the selectivity of the
treatment is more determined by the TRT than the wavelength of the laser.
In addition, new types of yellow lasers are emerging in the medical market as fully functional
medical systems [36, 37, 38]. This suggests that laser technology is finally catching up with the
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demands of the medical field, and it is now possible to tailor laser features to specific medical
applications, for example, with VECSEL technology, which is reviewed in the next chapter.
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3 VECSEL Technology
Chapter 3
VECSEL Technology
This Chapter provides an overview on the basic operation principles and characteristics of
VECSELs. The structure of a VECSEL gain mirror, pumping scheme, thermal management and
cavity configurations are described. The chapter will also present the concept of frequency
doubling and how it was applied to the lasers in this thesis.
 General concept
Optically-pumped vertical-external-cavity surface-emitting lasers (VECSELs) are high-brightness
light sources that convert higher energy (low wavelength) laser light into lower energy (high
wavelength) laser light via a semiconductor gain mirror. Historically, the concept of a VECSEL
dates back to 1966 when Basov et al. published a paper describing lasers with radiating mirrors
[39], but it took another three decades before the proposed concept was fully acknowledged and
the first working devices were demonstrated [40, 41]. Several more years were then needed before
the benefits of the technology were fully proven and a surge of new developments were triggered
[42, 43].
Figure 3.1 illustrates a typical VECSEL setup. Similarly to any other laser, VECSELs are
comprised of the three main laser components: the gain material, the cavity, and the pump source.
In VECSELs the gain is provided by the semiconductor gain mirror and the resonator cavity is
formed between the gain mirror and one (or more) external dielectric mirrors. In comparison, the
cavity for edge-emitting laser diodes (LDs) is formed between two cleaved surfaces of a
semiconductor waveguide. The LD waveguide is typically some hundreds of nanometres thick,
whereas the width is in the micrometre range. This large difference between the thickness and
width of the laser output aperture leads to beam asymmetry and, hence, poor beam quality in high-
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power operation. However, surface emitting lasers such as VCSELs (Vertical-cavity surface-
emitting lasers) and VECSELs avoid the issue of asymmetric beams by emitting vertically from the
surface of the semiconductor gain mirror through a symmetrical aperture. But a distinct difference
between a VCSEL and a VECSEL arises from the pumping scheme. VCSELs are electrically
pumped via metallic contacts, whereas VECSELs usually employ optical pumping which enables
larger active volume and higher output power. These two features (optical pumping combined with
surface emitting geometry) enable VECSELs to produce high-power emission while still
maintaining good beam quality.
Figure 3.1. Schematic illustration of a VECSEL depicting the basic properties. Not to scale
(semiconductor gain mirrors are typically only some hundreds of micrometres thick). Due to the
intrinsic low gain of VECSEL gain mirrors, only a few percent of the cavity power is coupled out
with the partially reflecting mirror.
In addition, the external cavity (further discussed in section 3.2) allows for the inclusion of
intracavity elements [44]. Typically, VECSEL cavities are in the order of centimetres or tens of
centimetres long, which makes it possible to insert nonlinear crystals for frequency conversion [45]
or wavelength selective elements, such as birefringent filters and etalons, to reach narrow
linewidth operation [46].  The external cavity also allows for the inclusion of a semiconductor
saturable absorber mirror (SESAM) leading to the generation of ultrashort pulses [47]. Another
significant advantage of VECSELs compared to laser technologies that use bulk lasing media (e.g.
solid state lasers) arises from semiconductor material engineering. Through careful design and
growth of the gain mirror, VECSELs can be tailored to emit at a specific wavelength needed in an
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application. Although, there are certain material limitations and challenges regarding some
wavelength ranges, which are shortly discussed in section 3.6.
 Gain mirror structure
A VECSEL gain mirror is comprised of two main components: a highly reflective mirror and a
semiconductor gain region. Often, they are both epitaxially grown on top of a semiconductor
wafer/substrate using either molecular beam epitaxy (MBE) or metalorganic vapour phase epitaxy
(MOVPE). A typical mirror structure is a so-called Distributed Bragg Reflector (DBR) mirror, which
is composed of a periodic stack of semiconductor material layers with alternating high and low
refractive indices. Roughly 20–25 pairs of low and high index layers are grown to achieve >99%
reflectivity for the VECSEL emission wavelength. In some specific cases, other types, such as
dielectric DBRs, metallic or hybrid mirrors have also been used [48, 49]. Moreover, DBR-free gain
structures (a so-called MECSEL) have also been realised, where the mirror section is replaced by
an external cavity mirror [50, 51].
The gain region usually includes several quantum well (QW) or quantum dot (QD) layers separated
by barrier layers. The purpose of the barrier layers is three-fold; they absorb the pump light, confine
the pump-generated carriers to the QWs for efficient recombination and in some cases
compensate for the strain imposed by the QWs on the structure. Whereas, the QWs determine
the emission wavelength of the VECSEL, which corresponds to the QW energy.
The total thickness of the gain mirror structure is usually less than 10 µm and the thickness of the
gain region even less (~2 µm) with each QW typically having a thickness of 4–12 nm [52]. Due to
this short interaction length between the laser mode and the gain material, the QWs are placed at
the antinodes of the optical field. This configuration is called a resonant periodic gain (RPG)
structure. In this way, the relatively low gain can be increased by maximising the coupling with the
QWs [1]. Moreover, if the QWs introduce a large strain to the gain structure, additional strain
compensation layers can be added in the active region [52]. A thin window layer concludes the
gain mirror structure and prevents non-radiative recombination at the surface. Figure 3.2 shows a
schematic example of a gain mirror structure. As a general rule, the centre of the DBR reflection
bandwidth, the QW material gain peak and the RPG resonance should coincide at the target
operation wavelength at the operation temperature for optimal performance.
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Figure 3.2. Schematic illustration of a VECSEL gain mirror band structure. Adapted from [P1].
 Optical pumping
Fibre-coupled multi-mode diode lasers are typically used to optically pump VECSELs. They are
low-cost, produce tens of watts of power and are readily available at several wavelengths thanks
to solid-state laser needs. However, in contrast to solid-state lasers, VECSELs are not so particular
with the pump laser wavelength. They absorb pump radiation in a broad wavelength range; the
energy of the pump laser photons just need to be higher than the VECSEL’s bandgap energy,
which is determined by the material composition. Usually, the gain structure is designed to absorb
most of the pump radiation in the barrier layers; the number of QWs and barrier layers are chosen
so that ~80% of the pump radiation is absorbed throughout the thickness of the gain region (QWs
placed beyond this point are unlikely to receive enough pumping for inversion). This ensures that
single-pass pump passage is sufficient to meet lasing condition. In another scheme, only the QWs
are designed to absorb the pump radiation, in which case the quantum defect (defined in the next
section) can be very low [53].
 Thermal management
VECSELs are sensitive to temperature rise and in the early experiments, high-power operation
was limited due to inadequate heat extraction techniques. The heating of the gain structure arises
from three main sources:  1) the quantum defect, 2) non-radiative recombination, and 3) pump
radiation that passes through the gain region un-absorbed (~20%) and is absorbed in the DBR
instead and transferred to heat [54]. The quantum defect is defined as the difference in energy
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between the pump laser photon and the VECSEL emission photon; this energy is lost to heat when
the high energy pump photons convert to the lower energy emission photons in the gain structure.
The main mechanism for non-radiative recombination is Auger recombination, which has a positive
feedback loop i.e. the probability of it increases with increasing temperature [55]. Excessive
heating caused by these three mechanisms leads to reduced efficiency via increased non-radiative
recombination and carrier leakage, which is further worsened when the pump power is increased
due to the positive feedback loop. Moreover, the increased temperature also red-shifts the
emission wavelength of the QWs, which can then lead to a mismatch between the emission
wavelength and the RPG resonance wavelength (which red-shifts slower than the emission
wavelength) [56]. This mismatch reduces gain, but can be compensated by designing the QWs to
emit at a shorter wavelength so that it matches the RPG resonance at high pump power [57, 58],
i.e. detune the emission and cavity wavelengths. If the pump-induced heating is not addressed
efficiently, a VECSEL’s output power will eventually exhibit so-called thermal rollover i.e there is a
point after which the output power only continues to decrease even if the pump power is increased
due to the negative temperature effects described above.
There are two general approaches to extracting heat from the gain mirror: the so-called intracavity
heat spreader and flip-chip approach, shown schematically in Figure 3.3. Both of them include
bonding a heat spreader element with high thermal conductivity to the gain mirror and further
extracting the heat with a water- or TEC-cooled heatsink. In the intracavity heat spreader approach,
a transparent heat spreader (such as diamond or other material with high thermal conductivity) is
capillary bonded [59] to the emitting surface of the gain mirror. The shortcomings of this approach
arise from the bonding process and the intracavity configuration. The bonding process is prone to
failure because small dirt/dust particles can easily prevent successful bonding if they get in
between the gain mirror and the heat spreader during the process. The elimination of such
particles is difficult even in cleanroom environment, and they often originate from the edges of the
cut gain mirror. Furthermore, the fact that the heat spreader is inside the cavity requires the
material to have low-absorption at the lasing wavelength and to be of high optical-grade quality,
which often leads to high cost. In addition, the heat spreader introduces intracavity losses and can
act as an etalon inside the cavity, thus, affecting the spectral features. In principle, the etalon effect
can be suppressed by employing a wedged heat spreader, but in this case an anti-reflective (AR)
coating is necessary to keep the reflection losses as small as possible [60].
In the flip-chip approach, the gain mirror structure is grown in reverse order so that the active
region is grown first on the substrate/wafer and the DBR mirror second. Next, the structure is
bonded to a heat spreader from the DBR side and the substrate is removed with wet-etching [42].
The benefit of this approach is that lower-cost diamond heat spreaders can be employed, because
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the heat spreader is not inside the cavity. However, the main difference to the intracavity approach
is that since the heat is removed through the DBR, the thermal resistance of the DBR has to be
as low as possible. This is challenging for some material systems that require thick DBR structures
(due to longer operation wavelength or poor index contrast of materials) or are made of materials
with high thermal resistance [61]. Other challenges in this approach also arise from the etching
and bonding processes. The gain mirror structure is very fragile without the support of the
substrate and the bonding process usually requires the use of temperatures exceeding 150 °C. If
there is a large difference in the coefficients of thermal expansions of the gain structure and of the
heat spreader, the fragile gain can experience detrimental mechanical stress as the bonding solder
cools down and hardens [61]. This is especially critical for hard solders, but the issue can be
alleviated by using soft solders, such as indium, or even alternative bonding methods [62, 63, 64].
Figure 3.3. Illustration of the two main heat extraction approaches: intracavity heat spreader and
flip-chip.
Both of the two heat extraction approaches have proved successful in enabling output powers in
excess of tens of watts. The highest output power measured to date, that is 106 W, is with the
flip-chip approach at a wavelength of 1028 nm [65]. The highest power recorded (72 W) with the
intracavity approach is presented in this thesis for a longer, more challenging wavelength of
1180 nm [P3]. In addition to the choice of heat extraction, one should also pay attention to
minimising non-radiative recombination by reducing defects in the gain structure and quantum
defect optimization by a proper choice of pump wavelength and barrier layer material. Yet another
approach to reduce the thermal load on a gain mirror is to pump with a pulsed laser. In this case,
more modest cooling assemblies and heatsink temperatures can be employed while still reaching
high peak powers [66].
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Finally, even more advanced cooling approach involves sandwiching the gain structure between
two heat spreaders [51] preceded by a total removal of the substrate, or even of the DBR as well
[50]. This membrane technology (referred to as MECSEL in section 3.2) could also provide a
solution to the problem of finding suitable material systems for direct emission at visible
wavelengths by eliminating the need of a monolithic DBR. Furthermore, stacking of these
membrane-heat spreader pairs could provide the means for further power scaling in the future.
 External cavity
The external cavity allows for the inclusion of additional cavity elements, such as nonlinear crystals
for frequency conversions, filters and etalons for linewidth narrowing and SESAMs for mode
locking. To this end, it enables VECSELs to offer a wide range of functionalities by extending the
wavelength coverage from IR to visible and UV, operation mode from high-power CW to ultrashort
pulses and spectral characteristics from multi-mode to single-frequency emission. The cavity
design is usually dependent on the desired functionality and in the simplest form resembles a letter
I in shape with only one external mirror deployed. Such a cavity is favoured in reaching record
output powers, and also for single-frequency operation due to larger spacing of longitudinal modes
i.e. larger free-spectral range (FSR) associated with shorter cavities [65, 46]. For frequency
doubling and mode locking with SESAMs, V- and Z-shaped cavities are preferred in order to
accommodate for the additional components and to provide a small mode waist or tight focusing
of the cavity beam. For power scaling purposes, it is also possible to employ multiple gain elements
in a single cavity [67, 68].
Laser light is coupled out of the cavity through one (or more) of the cavity mirrors, which has a
partially reflecting coating on it. These particular external mirrors are called output couplers (OCs).
The intrinsic low gain of VECSELs makes them vulnerable to high losses; hence, the transmissivity
of the output couplers is usually only a few percent. Typically, the VECSEL gain mirror acts as one
of the cavity mirrors, but it is also possible to include a DBR-free gain structure in between external
mirrors [50, 51]. This approach is particularly interesting for emission wavelengths that lack good
material to grow high-reflective DBRs. The common VECSEL cavity architectures are illustrated
in Figure 3.4.
Chapter 3. VECSEL Technology
26
Figure 3.4. Common VECSEL cavities: (a) straight I-cavity formed between a gain mirror (GM)
and an output coupler (OC), (b) V-cavity with frequency doubling with a nonlinear crystal (NLO).
The birefringent filter (BRF) fixes the polarization for the crystal and narrows spectrum, (c) cavity
with two gain mirrors, (d) Z-shaped cavity with SESAM for passive modelocking, (e) DBR-free gain
region (GR) in between two external mirrors. Note that pump laser optics are not illustrated for
simplicity.
In addition to frequency conversion and pulsing schemes, the external cavity also enables high-
power emission with good beam quality. The cavity design determines the size of the fundamental
mode on the gain mirror, which can be relatively easy to match with the pump spot to favour single
transverse mode operation (TEM00), i.e. Gaussian beam distribution. With power scaling in mind,
the mode size on the gain mirror can be designed to have a large diameter for larger gain volume,
and at the same time the matching large pump spot distributes the pump-induced heating to a
greater area. Single-frequency operation requires further suppression of longitudinal cavity modes
with filters and etalons.
  Wavelength coverage
The development of VECSELs has evolved along three main directions: i) power scaling, ii)
generation of ultrashort pulses (not covered in this thesis), and iii) wavelength coverage
[61]. To date, the wavelength range of directly emitting VECSELs spans from 665 nm to 5260 nm,
though not without gaps. This range is further extended to visible and UV wavelengths and beyond
5260 nm with frequency conversion via nonlinear crystals (discussed in the next section). Such a
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wide wavelength coverage, illustrated in Figure 3.5, is enabled by different material systems. The
gaps in the coverage are also bridged by the tuning capability of VECSELs. For example, tuning
ranges as broad as 43 nm at 1µm [69], 156 nm at 1.96 µm [70], and 900 nm at 5 µm [71] have
been demonstrated using intracavity filters.
Figure 3.5. Wavelength coverage of (mainly CW) VECSELs in relation to their output power.
Circles signify direct emission and stars frequency converted emission (2nd, 3rd or 4th harmonic or
difference frequency generation (DFG)). The boxed circles are pulsed VECSELs, but ultrashort
modelocked VECSELs are omitted from this illustration.
Most of the developments have focused on GaAs structures employing InGaAs QWs i.e. near 1
µm wavelength range, and, not surprisingly, the highest power [65] and shortest pulses [72, 73]
has been measured from VECSELs with ~1 µm emission. The advantage of this material system
is high reliability and high thermal conductivity [74, 75]. Moreover, GaAs/AlAs layers can be used
to fabricate high refractive index contrast DBRs with good optical properties. Material systems for
shorter wavelengths (360–920 nm) suffer from high strain and poor performance DBRs.
Particularly, there is a green-yellow wavelength gap that cannot be reached with direct emission
[1]. However, this material problem is circumvented by fabricating VECSELs in the 900–1300 nm
range and employing intracavity frequency doubling. Another approach could be to use a DBR-
free gain structures (MECSELs), but so far, the lowest wavelength reached with this method is
608 nm [76].
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It should be noted that wavelengths above 1100 nm are challenging to produce due to the strain
introduced by the multiple InGaAs QWs, which can lead to misfit dislocations and poor
performance. This problem is tackled by introducing strain compensation layers to the structure
[52] or incorporating small amounts of nitrogen into the QWs [77, 78]. The strain compensation
technique was used to obtain the 72 W at 1180 nm presented in this thesis [P3]. Whereas, the
dilute nitride method has resulted in the demonstration of a VECSEL emitting all the way at
1550 nm [79] and was used in the structure of the frequency-doubled red VECSEL included in this
thesis [P2]. The drawback of nitrogen incorporation is that it is associated with the formation of
point defects.
Typically, VECSELs emitting in the 1.25–1.6 range utilize InP structures with AlGaInAs QWs.
However, this material system suffers from low refractive index InP-based DBRs. Therefore,
instead of monolithic gain mirror structures, InP-based VECSELs often employ wafer bonded
GaAs-based DBRs [80, 81]. VECSELs emitting above 1.6 µm have been realised with GaInAsSb,
PbSe or PbTe QWs [82, 83]. These rather peculiar material systems benefit from high refractive
index contrast DBRs, but usually require low operating temperatures. Figure 3.6 illustrates the
wavelength coverage of VECSELs in connection to the material systems.
Figure 3.6. Wavelength coverage of VECSEs in relation to the used semiconductor gain materials.
Adapted from [1].
 Intracavity frequency-doubling in VECSELs
Nonlinear behaviour and frequency doubling, also known as second harmonic generation (SHG),
are already well established concepts and explained extensively in several textbooks [84, 85, 86,
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87]. Therefore, this thesis will only focus on the most important considerations needed to
understand the phenomenon and on what factors affect the conversion efficiency.
 Basic concept
As mentioned in the previous sections, the green-yellow spectral range is challenging to achieve
with direct emission. For this reason, intracavity frequency doubling of 1–1.3 µm VECSELs has
gained a lot of attention. It involves inserting a nonlinear crystal near the mode waist of a VECSEL
cavity. VECSELs are particularly suitable for intracavity doubling due to their high intracavity power
that can reach values in the order of 1000 W. Another advantage is that the infrared radiation is
circulated in the cavity, hence, the part that is not converted will travel through the nonlinear crystal
again. In other words, only a small fraction of the intracavity power needs to be converted per
round trip to achieve sufficient conversion. Typical optimum output coupling ratios for VECSELs
vary in the 1–5% range and, thus, similar 1–5% frequency conversion efficiency would be ideal for
the laser operation and still translate into tens of watts of frequency-converted light. In comparison,
to reach these values in external frequency doubling, one would have to achieve 100% conversion
efficiency, which is practically unattainable, especially for bulk crystals and with CW operation.
Figure 3.7. Illustration of the phenomenon of second harmonic generation (also known as
frequency doubling) in a nonlinear medium.
In simple terms, the phenomenon of frequency doubling can be described as light with frequency
i entering a crystal with nonlinear properties that converts it to light with frequency 2 i, i.e. twice
the frequency of the incident light (illustrated in Figure 3.7). In physical terms, it can be described
as two-photon absorption in a medium, which shifts the carriers to a higher energy level, after
which photons with twice the energy of the absorbed photons are emitted as the carriers return to
ground state. However, certain conditions need to be met before this process can occur efficiently;
these are addressed below.
Chapter 3. VECSEL Technology
30
 Phase matching, the effective nonlinear coefficient and selection of a
nonlinear crystal
There are two major factors to consider to achieve high-efficiency frequency conversion: phase
matching and the effective nonlinear coefficient, deff, of a crystal. The choice of an appropriate
crystal for a certain application is usually a compromise between these two. The effective nonlinear
coefficient describes the strength of the nonlinear interaction in a specific material. In general, one
should of course aim for as high deff value as possible, but this is sometimes not practical or
possible due to the phase matching constraints. The concept of phase matching relies on matching
the relative phases of the fundamental and the frequency converted light throughout the
propagation length inside a crystal. However, this is challenging to achieve in practice, because
the refractive index of a crystal material depends on the wavelength. Therefore, quite often we
encounter a phase mismatch, k, between the two light beams. This mismatch can be minimized
through careful consideration of different phase matching methods.
Phase matching methods are simpler to explain for uniaxial crystals, such as Beta-Barium Borate
(BBO). However, in this thesis we mainly used a biaxial crystal called Lithium triborate (LBO). The
difference in these two crystal types is the number of optic axes; uniaxial has one and biaxial two.
Biaxial crystals have a more complex function for light propagation, but we will confine ourselves
to the principle planes of XY, YZ and XZ, in which case a biaxial crystal acts as a uniaxial crystal
[87]. In practice, only these three principle planes are utilised for phase matching anyway.
In uniaxial crystals, the optic axis is usually denoted with Z and together with the light propagation
direction k it defines the principle plane. Light that is polarized orthogonally to the principle plane
is known as an ordinary ray, denoted with o, and its refractive index does not depend on the
propagation direction. Whereas, light that is polarised in the principle plane is called an
extraordinary ray, e, and its refractive index depends on the propagation direction. This difference
between the refractive indices is known as birefringence and it is one of the two basic methods to
achieve phase matching; if the fundamental and the frequency-converted rays have different
polarisations it is possible to match their refractive indices [85].
The dependence of the e-ray on the propagation direction is a function of the angle , which is the
angle between the optic axis and the propagation direction k. To achieve phase matching in a
uniaxial crystal, it should have a certain orientation defined by . This type of phase matching,
which relies on angle tuning, is called critical phase matching (CPM). For biaxial crystals, there is
also a second defining angle, . This is the angle between the projection of the light propagation,
k, on to the XY plane and the X-axis (shown in Figure 3.8). The drawback in this CPM method is
that the light does not propagate on the optic axis anymore. Consequently, the o- and the e-ray
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propagate at slightly different directions, which is referred to as spatial walk-off [87]. It can result
in elliptical output beams and reduced conversion efficiency. In addition, deff is affected by the
propagation direction which is determined by the angles  and .
Figure 3.8. Polar angles that define the propagation direction of light, k, in the crystal to achieve
phase matching in the birefringence phase matching method. Adapted from [87].
Spatial walk-off can be avoided in the special case of birefringent phase matching, called non-
critical phase matching (NCPM). In this case, the angle  is set to 90°, which places the light
propagation on the optic axis. The refractive indices are then matched by temperature tuning the
crystal.  The drawback for NCPM is simply the fact that it is not possible for all crystal materials
and wavelengths and sometime it requires very high or very low operating temperatures.
Some crystals do not exhibit birefringence, hence, another method is used to achieve phase
matching, called quasi phase matching (QPM) [84]. In this method, a nonzero phase mismatch is
allowed for a certain propagation length, but the deff is inverted after each coherence length
(defined as the distance where the conversion efficiency reaches its first maximum, inversely
proportional to k) so that the two waves converge back to the same phase. This periodically
poled structure can be established with various techniques, for example by applying an intensive
electric field through periodically patterned contacts [88]. Compared to birefringence phase
matching, QPM offers much larger deff and a wider wavelength coverage, since the poling period
can be adjusted to almost any wavelength (UV range is challenging for any crystal due to
absorption). Moreover, it does not require for the fundamental and the frequency converted light
to be of different polarisation, like in the case of CPM and NCPM. The drawbacks include higher
cost, fabrication challenges regarding the poling periods and they are more susceptible to damage
(e.g. via photorefractive effect) [89].
Another way to categorise phase matching is to use the notations Type 0, Type I, Type II. They
are defined by the polarisation of the interaction rays. For instance, Type I phase matching is
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achieved when two o-rays interact to produce one e-ray i.e. the fundamental and the frequency-
converted rays have different polarisations. Whereas, in Type II the two fundamental rays have
opposite polarisations. Type 0 is used to denote QPM in which all the interaction rays have the
same polarisation. Type I and II are covered in CPM and NCPM and further divided into minus
and plus interactions depending whether the crystal acts as a negative or positive crystal [87].
Table 3.1 attempts to summarize all the phase matching types and methods, and how they relate
to the polarisation of the interaction rays.
It should also be noted that there are higher harmonic generations than just SHG, such as third
harmonic and fourth harmonic, but they are seldom used directly due to the low third and fourth
order nonlinearity in materials. Typically, cascaded processes with two crystals of second order
nonlinearity are employed [90]. In fact, second order nonlinearity is divided into sum-frequency
generation (SFG) and difference-frequency generation (DFG), and SHG is simply a special case
of SFG. Although, it is the most used type because it employs only one pump laser.
Table 3.1. Phase matching types and methods.
Type Polarisations of the Interaction rays
(Principle plane for biaxial crystals)
Method
Type 0 e + e  e QPM
Type I o + o  e (XY) CPM (NCPM for certain
crystals if  = 90° and  = 0°)
e + e  o (XZ)
Type II e + o  e (XZ)
CPM
o + e  o (YZ)
To summarize, understanding frequency conversion in nonlinear crystals and choosing a suitable
crystal is not a trivial matter. Phase matching (or rather phase mismatch) and deff are the main
factors that affect the efficiency of the conversion, but other factors such as the length of the crystal
and power density of the laser light also play a role. The choice of a suitable crystal usually starts
with finding a material, which is transparent for the laser wavelength and has a high enough deff
for a suitable type of phase matching. For this purpose, one can use a software, such as SNLO
[91], to find phase matching solutions and their deff for various cases. Another major factor that
affects the experimental conversion efficiency values is the crystal quality. The facets of nonlinear
crystals are also often anti-reflection coated for the pump and frequency converted wavelengths.
The quality of the coatings can also significantly affect the conversion efficiency, particularly in an
intra-cavity configuration. LBO crystals are known for a wide transparency, high damage threshold,
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high deff and NCPM option, which is why it was the material of choice for the doubling crystals in
this thesis.
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4 Laser Results
Chapter 4
Laser Results
This chapter reviews the laboratory-environment laser demonstrations in this thesis. The first
section reports the results for a CW frequency-doubled yellow VECSEL including a tuning
experiment and pulsed operation. The second section presents the output characteristics of a
frequency-doubled red VECSEL in CW and pulsed mode with further investigations on the
conversion efficiency of the doubling crystal. The third and final section reports the record power
for a VECSEL emitting in the 1.2-µm range. All the gain structures in this thesis were grown by
molecular beam epitaxy (MBE).
Figure 4.1. Frequency-doubled yellow VECSEL in operation. Results presented in section 4.4.
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 Frequency-doubled yellow VECSEL (20 W)
The 1180-nm gain mirror presented in [P1] was designed and grown for frequency doubling to the
yellow spectral range. As discussed in Chapter 2, there is a need for high-power yellow lasers in
medical and life science applications, as well as in other fields, such as astronomy.
 Experimental set-up
The gain mirror structure was designed to emit 1180-nm emission. A 25.5-pair AlAs/GaAs DBR
was grown on top of a GaAs substrate followed by the gain region, which incorporated 10 InGaAs
QWs sandwiched in between GaAs barrier layers and GaAsP strain compensation layers. The
intracavity heat spreader approach was employed for efficient thermal management. This included
capillary bonding a diced 2.5 mm x 2.5 mm VESCEL chip onto a 300-µm-thick intracavity diamond
heat spreader. Moreover, the diamond was attached to a water-cooled copper mount via indium
foil.
Figure 4.2. Cavity configuration for the frequency-doubled yellow VECSEL [P1].
The cavity was designed for frequency-doubling and employed two external mirrors forming a V-
shape along with the gain mirror, shown in Figure 4.2. The flat end-mirror had HR coating for both
the fundamental and the yellow wavelengths, whereas, the folding mirror was highly transmissive
for the yellow and HR for the fundamental. This enabled us to have high intracavity power for the
fundamental emission and to measure the frequency-doubled output from one direction.
A 1.5-mm-thick birefringent filter (BRF) was placed at a Brewster’s angle in the first arm of the
cavity in order to fix the polarization of the fundamental emission, to narrow the spectrum and
enable wavelength tuning. A 100-µm-thick etalon was placed next to it to further narrow the
Chapter 4. Laser Results
36
spectrum. The gain mirror was pumped with an 808-nm diode laser. The pump radiation was
focused to a spot with a diameter of 510 µm (1/e2). The fundamental mode size on the gain mirror
was slightly smaller than the pump spot. It is easier to obtain fundamental transverse mode
operation if the pump and the mode size are matched, but a compromise was made to produce a
favourable mode waist for the doubling crystal.
The doubling crystal was chosen to be a 10-mm-long NCPM lithium triborate (LBO), because of
its high deff, high damage threshold, and absence of walk-off. The facets of the crystal were flat
and AR-coated for the fundamental and the yellow radiation. Phase matching was achieved by
temperature tuning the crystal around 38°C. This was achieved by enclosing it in a TEC-stabilised
copper oven. We noticed some damage on the AR-coatings after the CW measurements, which
is why we employed a 10-mm-long CPM LBO for further experiments with a pulsed pump laser.
The damage was visible to the eye and further investigations with an optical microscope convinced
us that only the coating was damaged and not the crystal itself. We attributed this damage to the
high intracavity power incident on the crystal facet (~3 MW/cm2). It could have also started from a
burnt dust particle and escalated as the pump power was increased.
 Continuous wave operation
A record output power of 20 W of yellow radiation was measured behind the folding mirror. This
corresponded to an estimated absorbed pump power (reflected power from the crystal surface
subtracted from the incident pump power) of 75 W and a mount temperature of 8.3°C. The highest
optical-to-optical conversion efficiency of ~28% (from absorbed pump power to yellow output) was
recorded for 16 W of output power. The emission spectrum was centred at 588.1 nm with a FWHM
of <0.2 nm. The output power characteristics along with the spectral features are shown in Figure
4.3 (Left). The beam profile for the yellow radiation was preserved circular with some distortions
as seen in Figure 4.3 inset (partly caused by dust specs on the CCD camera). In addition, the
tuning range of the frequency-doubled VECSEL was determined by rotating the BRF around its
axis. For this experiment, the pump power was kept constant at 55 W and the temperature of the
LBO oven was optimised for each wavelength separately*. This resulted in a tuning bandwidth of
~26 nm ranging from 576 nm up to 602 nm (Figure 4.3 Right). The 20 W of yellow is to date the
highest power achieved at this wavelength range for this type of laser and it is also among the
best results in the visible range alongside with the 30-W result at 532 nm reported by Coherent
Inc. [45].
* The temperature dependence of NCPM LBO is well-known and the phase matching temperature
can be calculated using Sellmeier’s equations [119].
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Figure 4.3. Left: Output power characteristics for the frequency-doubled yellow VECSEL. Beam
profile and spectrum at maximum power as insets. Right: Tuning curve and the corresponding
output powers (right y-axis) [P1].
 Pulsed operation
Pump-induced heating of the gain structure causes thermal rollover and limits the CW operation.
In addition, certain (medical) applications require pulsed laser light. In order to study the thermal
effects and improve the conversion efficiency, a pulsed pump laser was employed. The same
cavity configuration was used as with the CW measurements, however, the NCPM crystal was
substituted with a CPM crystal due to damaged AR-coating. The temperature of the CPM LBO
was kept near room temperature and the gain mirror mount temperature stayed at 21°C throughout
the pulsed operation experiments corresponded to a water coolant temperature of 20°C.
The pump laser was driven with a driver capable of producing pulse widths up to ~1.5 µs. Two Si-
based detectors were deployed to monitor the light pulse shapes generated by the VECSEL and
the pump laser, shown in Figure 4.4 (Left). First, the driver was set to produce 1.5 µs pulses and
then to 1.0 µs while keeping the repetition rate constant at 10 kHz. These pulse settings produced
1.08 and 0.57 µs pulse widths (FWHM) for the yellow radiation. For a reliable comparison with CW
operation, we also measured the power characteristics generated by the new CPM crystal with a
CW pump for a coolant temperature of 20°C.
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Figure 4.4. Left: Pulse shapes for the pump laser driver (black trace), pump laser output (red
trace), and frequency-doubled VECSEL output (yellow trace) for 1.5 µs pulse width setting. Right:
Output power characteristics for CW (average power) and pulsed operation at two different pulse
width settings. Output spectrum for 0.57-µs pulse width at maximum power as an inset [P1].
Figure 4.4 shows clear thermal rollover behaviour for the CW measurement, whereas, pulsed
operation shows linearly increasing trend, limited by the available peak pump power (70 W).
Moreover, the optical-to-optical conversion efficiency of the CW operation at maximum output
power was 15%, whereas, for the pulsed operation the conversion efficiencies were 20% and 21%,
for the 1.08 µs and 0.57 µs pulses respectively. The maximum output power reached in CW
operation was 8.5 W compared to the maximum peak powers of 13.8 W for the 1.08 µs pulse and
14.1 W for the 0.57 µs pulse. The output characteristics of the pulsed operation experiments are
shown in Figure 4.4 (Right) with yellow spectrum for the 0.57 µs pulse as an inset. The FWHM of
the spectrum for each pulse width were almost equal: 0.119 nm for 1.08 µs pulse and 0.113 nm
for 0.57 µs pulse.
 Frequency-doubled red VECSEL (10 W)
The 1230-nm gain mirror presented in [P2] was designed and grown for frequency doubling to the
red spectral range. As discussed in Chapter 2, there is a need for high-power red lasers in
medicine and life sciences, and potentially also in laser display technology; with further conversion
to the UV range, red VECSELs also find applications in quantum optics.
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 Experimental set-up
The resonant gain mirror structure was designed to emit in the 1230-nm range and incorporated
dilute nitride to enable the longer infrared emission. The gain region was comprised of 10 GaInNAs
QWs surrounded by GaAs barriers. The nitrogen composition in the QWs was 0.5% and the whole
structure was annealed after the growth to improve the material quality. Similar thermal
management configuration was employed as with the 1180-nm material. A diced 3 mm x 3 mm
chip was capillary bonded to a 300-µm-thick diamond heat spreader, which was attached to a
water-cooled copper heatsink.
Figure 4.5. Cavity configuration for the frequency-doubled red VECSEL [P2].
The VECSEL was built into a V-shaped cavity formed by the gain mirror and two curved dielectric
mirrors, shown in Figure 4.5. The gain mirror was pumped with an 808-nm diode laser, which was
focused to a spot size of ~400 µm (1/e2). The total length of the cavity was ~147 mm and the mode
diameter on the gain mirror was ~240–300 µm (elliptical due to the folded cavity architecture). All
the cavity mirrors were highly reflective for the fundamental emission and the curved end-mirror
was also HR for the red emission. The folding mirror had high transmission for the red emission.
We measured the reflectivities of the mirrors experimentally in order to estimate the intracavity
power of the fundamental emission from the leakage of the HR mirrors. This included measuring
the laser beam before and after the mirrors at different wavelengths in order to calculate the
transmitted/reflected part of the beam.
A 1.0-mm-thick BRF and a 100-µm-thick etalon were placed in the first arm of the cavity to fix the
polarization and narrow the linewidth of the laser. In addition, the same 10-mm-long NCPM LBO
that was used with the yellow VECSEL was placed near the cavity mode waist for efficient
frequency doubling. Phase matching was achieved by tuning the crystal’s temperature to ~20°C.
The temperature was first estimated with Sellmeier’s equations and then adjusted experimentally
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to produce the highest output power. CPM crystals were also tested, but even with the damaged
AR-coating the NCPM LBO generated the highest conversion. This could be expected, since the
NCPM LBO has higher deff than CPM LBO.
 Continuous wave operation
The red emission was measured behind the folding mirror. The VECSEL reached a maximum of
10.5 W for an absorbed pump power of 59.7 W. This corresponded to an optical-to-optical
conversion efficiency of 17.5% and was achieved for a mount temperature of 5–8°C. The emission
wavelength was centred at 615 with a FWHM of 0.4 nm. The beam profile shows an elliptical
shape, which might be consequence of the multi-transversal mode operation potentially caused
by the difference between the pump spot diameter and the mode size on the gain mirror. The
output power characteristic are shown in Figure 4.6 (Left). The beam profile and the output
spectrum are shown as insets and were recorded at 7 W of output power.
Figure 4.6. Left: Output power characteristics for the frequency-doubled red VECSEL. Beam
profile and spectrum as insets, recorded at 7 W of output power. Right: Intracavity power (blue
circles, left y-axis) and single-pass conversion efficiency, , (red squares, right y-axis) of the NCPM
LBO crystal [P2].
Figure 4.6 (Right) shows the calculated intracavity powers as a function of the absorbed pump
power. The single-pass conversion efficiency (optical-to-optical), , of the crystal was calculated
by using the intracavity power together with the measured red output power and is also displayed
in Figure 4.6 (Right). The intracavity power was estimated by measuring the leakage of IR radiation
from the HR flat end-mirror. The small drop visible on the single-pass conversion curve is due to
the small power drop in the red output power. This was probably caused by a wavelength jump,
which we have often observed in frequency-doubled VECSELs that are not perfectly temperature
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stabilised. The same drop is not observable on the intracavity power curve probably because the
IR leakage value might have been recorded right before the wavelength jump. The maximum
single-pass conversion efficiency of 0.8% corresponds well to the optimal output coupling of the
1230-nm gain material, which was determined to be 1.5% by experimentally testing different output
couplers. In the intracavity configuration, the fundamental emission travels to both directions inside
the crystal hence the total conversion efficiency was 1.6%.
 Pulsed operation
The red VECSEL was also tested in pulsed operation in order to achieve higher conversion
efficiencies. The cavity was kept as it was; only the pump laser was changed to the pulsed 808-
nm diode laser. The pump laser driver was set to produce 1.5-µs pulse widths, in which case the
red output had a pulse width of 1.16 µs (FWHM). The pulse waveforms measured at the maximum
output power are shown in Figure 4.7 (Left). During the measurements the mount temperature
stayed at 20°C. For comparison, a power curve in CW mode was also measured for a mount
temperature of ~20°C. Figure 4.7 (Right) shows the recorded output characteristics for both
operation modes. The maximum output power achieved in CW mode was 8.0 W, whereas, in
pulsed mode the maximum peak output power was 13.8 W. Furthermore, thermal rollover was
reached in the CW operation, but the pulsed operation was pump power limited. The maximum
optical-to-optical conversion efficiency in pulsed operation was 20.4%, which is approximately 3
percentage points more than in CW operation.
Figure 4.7. Left: Pulse shapes for the pump laser output (black trace), and frequency-doubled
VECSEL output (red trace) Right: Output power characteristics for CW (average power) and
pulsed operation at two different pulse width settings. Output spectrum for 1.16-µs pulse width at
maximum power as an inset [P2].
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 High-power 1180-nm VECSEL (72 W)
A new gain structure was fabricated for 1180-nm emission in [P3] in order to provide chips for a
yellow VECSEL system designed for medical use. In addition, the structure aims at satisfying the
challenging narrow-linewidth requirements set by the laser guide star adaptive optics.
 Experimental set-up
The gain mirror was comprised of an active region with 10 GaInAs QWs grown on top of a 26-pair
AlAs/GaAs DBR. The strained QWs were embedded between GaAs barrier layers and GaAsP
strain compensation layers. The structure was terminated with a GInP window layer to prevent
surface recombination, and the active region thickness was matched to make the gain mirror
microcavity resonant at the fundamental wavelength.  This resonant structure along with carefully
optimised detuning, provided the increased gain for the new 1180-nm gain mirror as compared to
the one used in section 4.1.
In addition to the new improved gain mirror, heat extraction from the gain mirror was also improved
by using a thicker, 2-mm intracavity diamond heat spreader. Furthermore, instead of a compact
water-cooled copper mount, a 200-mm-thick copper plate cooled with four 200-W thermoelectric
coolers (TECs) was employed to further extract the heat away from the gain mirror. The new high-
gain material and the advanced cooling assembly enabled to reach much higher powers than
before.
Figure 4.8. Cavity configuration for the high-power 1180-nm VECSEL. The BRF and etalon were
employed only in the longer cavity (l = 130 mm, RoC = 250 mm) for narrowing the spectrum [P3].
This time a simpler cavity configuration was designed, since there was no need to fit a nonlinear
crystal inside the cavity. Only one external mirror was employed forming a 109-mm-long I-shaped
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cavity with the gain mirror, illustrated in Figure 4.8. The 808-nm pump light was supplied by a
200-W diode laser. The light was focused to a rather large top-hat spot size of 950-µm in diameter
(4  value) to provide lateral power scaling. The VECSEL was first measured in free-running, but
a longer I-cavity (130 mm) was built to demonstrate the feasibility of the laser for narrow-linewidth
operation.
 Continuous wave operation
Different output coupling ratios were tested with the free-running cavity and the highest power was
yielded with a 3%-coupler. Output power curves were measured at three different heatsink
temperatures of 0, 10 and 20°C and plotted as a function of the incident pump power in Figure 4.9
(Left). The incident pump power is defined as the total power incident on the diamond surface and
does not take into account the reflections from the diamond surfaces (estimated to be 5% with the
AR-coating). The VECSEL reached a maximum of 72 W at a heatsink temperature of 0°C. This
corresponded to 257 W of incident pump power, 29% optical-to-optical conversion efficiency and
38% slope efficiency. To date, this is the all-time second highest power reported from a VECSEL,
only surpassed by the 106-W VECSEL at 1 µm, which is based on the more mature InGaAs/GaAs
material system [65]. Thus, further merit is given to the result with the more challenging wavelength
range of ~1.2 µm. During the 72-W operation, the spectrum of the laser was centred at 1185.5 nm
and the FWHM was measured to be 5.5 nm, shown as an inset in Figure 4.9 (Left). At heatsink
temperatures of 10 and 20°C, the maximum output powers were 62 and 53 W, respectively.
Figure 4.9. Left: Output power curves for heatsink temperatures for 0, 10, 20°C. Lasing spectrum
recorded at 72 W of output power is shown as an inset. Right: Normalised linear lasing spectrum
at the maximum power (19 W) from the cavity including a 5-mm-thick BRF and a 250-µm-thick
YAG etalon. Beam profile measured at 19 W of output power shown as an inset [P3].
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 Narrowing the spectrum
The cavity was extended to make room for the intracavity filters. For reference, the output power
of the longer cavity was first measured with a 3% output coupler. A maximum of 25 W was
measured for a heatsink temperature of 20°C. Next, a 1.5% coupler was employed to compensate
for the losses produced by the added intracavity filters. In this setup, a 5-mm-thick quartz BRF and
a 250-µm-thick YAG etalon were inserted into the cavity and the lasing wavelength was fixed to
~1178 nm. A maximum of 19 W of output power was measured at 20°C, and the FWHM linewidth
of the uncovered table-top laser was 0.06 nm (Figure 4.9 (Right)). The beam profile showed
fundamental transverse mode operation (shown as an inset in Figure 4.9 (Right)).
The purpose of this wavelength narrowing was to demonstrate that high-power single-frequency
operation would be possible in future with appropriate mechanical design. In the future work, a
thicker BRF might be beneficial to further damp the unwanted cavity modes. In an earlier
demonstration by Zhang et al. single-frequency operation was reached with a 10-mm-thick BRF
[46]. This thesis work was confined to the existing stock in the lab.
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5 Clinical Trials
Chapter 5
Clinical Trials
As a final step in this thesis, the developed yellow VECSEL was applied in a clinical trial for a
proof-of-concept demonstration [P5]. This included first developing the laboratory laser into a fully
functional system that can be operated by physicians, presented in [P4]. This chapter reviews the
preparations required to perform clinical trials regarding the laser system, as well as regulatory
considerations. Sections 5.1 and 5.2 present the design consideration and the operation features
of the yellow VECSEL system. Documentation and permit requirements are listed in section 5.3.
Finally, the design of the clinical protocol and the results of the trial are reported in sections 5.4
and 5.5.
 General consideration in designing a device for
clinical use
Safety is the most important consideration when designing a medical device for commercial or for
investigational purposes. International Organization for Standardization (ISO) has set specific
safety standards for electrical medical devices in their document ISO/IEC 60601-1. Other ISO
standards to consider are risk management for medical devices (ISO 14971) and ISO 14155,
which addresses the good clinical practice for the design, conduct, recording and reporting of
clinical trials [92]. European Union also has its own directive, namely Medical Device Directive
(MDD), whose main purpose is to standardize the laws relating to medical devices within the
European Union. Devices that comply with these standards are given a CE-mark and can enter
the commercial market [93].
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It is necessary to have a good understanding of these standards before starting the design process
of a medical device. For example, electrical connections in the device must comply with the ISO
60601-1 standards to ensure the safety of the user and the patient. Some of this workload can be
reduced by using already CE-marked power sources and drivers. Electromagnetic compatibility
(EMC) is also an important factor to consider. Treatment rooms are often scattered with various
electrical equipment (some of which can be vital to the patient health), hence, it is important that
the new medical device does not interfere with the surrounding electrical devices, or vice versa. It
is also important to make sure that the materials, such as used optics and outer casings, do not
pose hazards to the patient, particularly if they are in contact with the patient.
In addition to safety, it is important to design the laser features to match the needs of the
application. Chapter 2 reviewed the light-tissue interactions in the context of dermatologic
applications and the laser parameters that affect the outcome of a laser treatment. In general, the
most important features are the lasing wavelength and the delivered energy, which is determined
by the pulse duration and the intensity of the laser beam. It was also shown that there is a need
for a yellow laser in the field of dermatology for the treatment of superficial unwanted blood vessels.
For this purpose, ideally a laser should operate in the 580–590 nm wavelength range, produce 1–
100 ms second pulses and deliver fluences in the order of 5–20 J/cm2. The reliability and stability
of these operation parameters is also a safety issue, since the treating physician needs to be able
to trust that the laser produces the parameters he intends to treat the patient with.
 Yellow VECSEL system
The yellow VECSEL system was designed and built in the Optoelectronics Research Centre
(ORC), Tampere University of Technology, in collaboration with the French National Institute of
Health and Medical Research (INSERM). It was based on the work done with frequency-doubled
VECSELs and the system features were tailored to match the needs of dermatology applications.
 Laser module
The laboratory setup of the frequency-doubled yellow VECSEL presented in section 4.1. was
developed into a compact laser module. The VECSEL employed the gain mirror structure
presented in section 4.3 and a LBO crystal for frequency doubling. A commercial 808-nm diode
laser was used to pump the gain mirror. The VECSEL cavity (similar to the one shown in Figure
4.2) was assembled and sealed inside an airtight aluminium housing, shown in Figure 5.1 (Left).
All the cavity components were glued on a baseplate for a robust finish. The baseplate was
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temperature stabilized, but the most critical cavity components, such as the LBO crystal, also had
their own temperature control. Dielectric mirrors were used to steer the yellow output beam through
a collimation lens and towards a fibre port. The dielectric mirrors also act as wavelength filters to
remove residual fundamental radiation from the output beam. In addition, a beam pick-off was
placed in front of the fibre port to direct a small portion of the output beam into a photodiode for
monitoring the output power. The collimated output beam was then coupled into a multimode fibre
with a core diameter of 200 µm. In case we needed to change the fibre, the photodiode was
calibrated again since the coupling efficiency is sensitive to even small alignment deviations. We
observed a maximum of 10% change in output power, but most often it was far less.
The output power delivered by the module as a function of the incident 808-pump power is shown
in Figure 5.1 (Right). The VECSEL operated in CW mode and a maximum output power of 8.6 W
was achieved at an emission wavelength of 588 nm. CW operation was chosen, rather than pulsed,
because it is relatively easy to mechanically pulse the laser light to produce 1–100 ms light pulses.
This was achieved by utilising a fibre port and a handheld scanner presented in section 5.2.2.
Power stability is also an important factor in medicine so that physicians can be certain of how
much light energy they are using per treatment. The module was tested by measuring the output
power of the system through the optical fibre for 15 minutes (shown in Figure 5.2), which
corresponds to a typical treatment time. The laser was set to emit ~4 W (typical treatment output
power) and the corresponding standard deviation of the output power was only 2.6 mW.
Figure 5.1. Left: Photo of the VECSEL module accompanied by a 20-cm ruler. Right: Output power
characteristics along with the beam profile (measured at the focus of the handheld scanner) and
lasing spectrum shown as insets [P4].
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Figure 5.2. Output power stability of the VECSEL module shown as a function of time. The yellow
laser was set to emit ~4 W and a power meter was used to collect data for 15 minutes [P4].
 System features
The VECSEL module was integrated into a laser system resembling a table-top computer in size,
shown in Figure 5.3a. The system encloses the VECSEL module, the pump laser and custom-
built electronics. It is powered-up with a mains switch in the back panel and a turn-key switch in
the front panel. The key switch enables the system usage and activates a 30-second warm-up
period, after which the laser is in Standby-state and can be ramped up to a wanted power level.
The treatment parameters are controlled using a touch screen on top of the system, shown in
Figure 5.3b. The varied parameters are laser power and pulse length with typical ranges of 0–7 W
and 10–100 ms, respectively. These parameters, along with the spot size of the output beam,
determine the treatment fluence, which is automatically calculated and displayed on the touch
screen. The system produces a spot size of 1.4 mm in diameter (Gaussian intensity distribution)
allowing to reach treatment fluences up to 52 J/cm2, which is sufficient for treating superficial blood
vessels. Compared to the pulsed dye laser (PDL), the 1.4-mm spot size is relatively small meaning
that more spots are needed to cover the same area as with a PDL. In the VECSEL system, this
shortcoming is overcome by employing a handheld scanner (shown in Figure 5.3c), which directs
the fibre-coupled light onto skin in a pre-defined pattern. Using such a scheme with a typical pulse
duration of 25 ms (i.e. 25 ms dwell time on each treatment spot), an area of about 1 cm2 can be
covered in less than a second. The smaller spot size also sets lower power requirements for the
laser light, since the necessary fluences can be reached with lower output powers. In addition, the
use of a scanner also brings flexibility enabling a diverse choice for treatment areas via
programming. It should be noted that the1.4-mm spot size was determined by the optics inside the
scanner, hence other spot sizes could be made available with different hand pieces. However, the
current programming and fibre connections only support the used handheld scanner, which was
supplied by MedArt A/S (Denmark).
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Figure 5.3. Photo of the yellow VECSEL system (a), the touch screen (b) and the handheld
scanner (c) [P4].
The scanner has three different settings that can be varied by pressing the buttons on the side of
it: scan pattern, scan area size and spot density. The available scan patterns include a single spot,
line, square and hexagon profiles. Compared to the pulsed dye laser, which usually provides only
circular beam spot profiles, these settings offer the user the freedom to select the most appropriate
pattern for each situation and in principal avoids the problem of overlapping and un-treated areas
caused by a circular spot. The scanner also includes a metallic distance piece attached to the front
to indicate the correct treatment distance of 27 mm. The scan patterns are listed in Table 5.1 and
illustrated in Figure 5.4. The delivery of laser light is activated by pressing a foot pedal connected
to the back panel of the device; the foot pedal opens a shutter blocking the yellow beam and
initiates the operation of the laser scanner. Once the scanner has covered the predetermined
treatment area, the shutter is automatically closed.
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Figure 5.4. Illustration of the scanning patterns (courtesy of MedArt A/S) [P4].
Several safety measures have been implemented to the system in order to prevent any accidental
light emission when the system is on. These features require that the handheld scanner and the
output fibre are connected to the system before the shutter can be opened by the foot pedal.
Moreover, the system also has to be at the target power level to enable light emission; if the output
power is not within 0.1 W of the target, light is not emitted even if the foot pedal is pressed. Finally,
the system is also equipped with an interlock that can be connected to a trigger signal, which turns
the laser off if unauthorized personnel enter the treatment area.
Altogether, the air-cooled system weighs about 30 kg and is portable. The system does not have
wheels, but for easier transfers it could be enclosed inside a wheeled suitcase. The technical
specifications of the system are listed in Table 5.1.
5.3    Documentation and regulatory requirements
51
Table 5.1. Technical specifications of the yellow VECSEL system [P4].
Technical Specifications
Basic features
Wavelength 585 ±5 nm
Power up to 8.6 W in CW
Size 64 x 26 x 60 cm3
Weight approx. 30 kg
Treatment parameters
Spot size 1.4 mm diameter
Pulse length 10–100 ms
Fluence 0–52 J/cm2
Scan patterns Line, square, hexagon
Scan area From single spot up to 1 cm2
Spot spacing Low, medium and high density
 Documentation and regulatory requirements
It is essential to document the technical data of the investigational medical device, as well as other
considerations, such as risk management and various tests. They are important to keep for own
records, but they are also required when applying for a permit to commence a clinical trial. In
Finland, a favourable statement is required from the local ethical committee and the final permit is
given by the National Supervisory Authority for Welfare and Health (Valvira). Figure 5.5 lists most
of the documents prepared for the clinical trial. The main document packages were Risk
Management, Investigator’s Brochure and Clinical Protocol. The documentation process is rather
long and it is further extended by the waiting time for the permit applications. It took approximately
one year from the start of the documentation process to reach the start of the trial.
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Figure 5.5. Flowchart of the documents required for a clinical trial.
 Risk management
Risk management is an important process in developing a device, which aims at minimizing the
probability of unfortunate and harmful events. It involves identifying, classifying and controlling all
potential events associated to the device that may cause harm to people, the environment, the
equipment, or to the device itself. These events may originate from various sources such as
manufacturing or users.
Figure 5.6. Flow chart of the Risk Management process.
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The potential risks of the yellow VECSEL system were divided into four categories: risks specific
to treatment, risks specific to use of lasers, risks specific to programmable electrical medical
systems and risks specific to medical devices. Each risk was also given a numeric value (1–5) to
represent the probability and severity of the risk. The multiplication product of these values gives
the overall level of risk and places each risk into one of the three categories: Acceptable (1–6),
ALARP (as low as reasonably practicable) region (7–14), Intolerable (15–25). All risks located in
Intolerable-class were then reduced by preventive Risk Control Measures (RCM’s) to either
ALARP-area or acceptable area. A final evaluation of the residual risks was performed after the
implementation of RCMs. Figure 5.6 illustrates the risk management process and the main risks
and their control measures identified for the yellow VECSEL system are listed in Table 5.2.
Table 5.2 Main risks identified for the yellow VECSEL system and their control measures.
Description Proba
bility
Seve
rity
Risk
Rate
Risk Control Measure (RCM) Proba
bility
Risk
Rate
Overdose of light
(too high optical
output power),
produced by the
laser
3 4 12 Maximum output power is limited to 6-
10 W (depending on the module)
1 4
Display fluence of the light dose
clearly on the device
If output power is not within the error
limits (±200 mW) the foot pedal is
disabled
Handheld scanner
malfunction
(wrong pattern,
too large/small
spot size, does
not produce any
light etc.)
4 4 16 Verify the scanner functionality and
compatibility with the main unit
1 4
Follow the scanner’s test procedure
before treatment (see MedArt scanner
manual)
Ocular exposure
to laser radiation
3 5 15 Prevent unintentional launch of laser
light by integrating proximity sensor to
fibre port and interlock functionality.
1 5
Systematic wearing of protective
goggles with appropriate specifications
(at least OD 5+ at 580–590 nm)
Software
malfunction
5 5 25 Test and verify software 1 5
Servicing electric
shock
3 5 15 Warning that unit to be serviced only
by trained/authorized personnel
1 5
Use by untrained
physician/other
2 5 10 Warning caution in instruction manual 1 5
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 Investigator’s brochure
The Investigator’s Brochure (IB) is a so-called umbrella document, which collects and summarizes
main information from the other documents. It is intended to provide the clinical investigators’ a
comprehensive but compact information package of the investigational device. It lists the device
features and specifications and presents the results of risk management and preclinical tests.
Other larger documents that are prepared in conjunction with the IB are Operation Manual,
Preclinical Tests and Literature Review. In particular, the preparation of the Literature Review was
a time consuming process that involved going through many lists of literature (mainly journal
articles) given by chosen search databases (such as Google scholar and PubMed) for
predetermined search terms. This review provided the basis for the justification to perform the
designed clinical trial. Preclinical Tests included mechanical, electrical and EMC testing. Moreover,
the reliability of the system was also tested by measuring the repeatability (and stability) of the
system in terms of the scanner operation, shutter operation and laser output.
 Clinical protocol
The design of the clinical protocol is especially important: it should be justified, clear and yield
meaningful results. The protocol is usually designed with the clinical investigators and includes the
preparation of many practical and compulsory patient related documents, such as information
leaflet, subject consent form and self-evaluation forms. Ethicality of the protocol also needs to be
explicitly considered in a separate statement by the clinical investigators. The next section gives
a summary of the clinical protocol designed to test the efficacy of the yellow VECSEL system.
 Clinical trial protocol
 Objectives and background
The primary objective of the study was to compare the clinical outcome and adverse events of
treating facial telangiectasias (dialated blood vessels) with traditional KTP-laser and the new
investigational yellow VECSEL system, namely PhotoLase† laser, in a double-blinded randomized
split-face trial. Both devices are Class 4 lasers with slightly different wavelengths, 532 nm for KTP
and 585 ± 5 nm for PhotoLase. The secondary objective was to assess the usability, reliability and
treatment characteristics of the PhotoLase laser from the perspective of the user. The hypothesis
† not trademarked, working-name during the project/trial
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was that the new investigational device PhotoLase is as good or better in treating facial
telangiectasia as the conventional KTP laser and does not produce more adverse/side effects.
 Subject selection
Volunteering adults with Fitzpatrick’s skin phototype I-IV and symmetrical facial telangiectasia
were included in the trial. Ordinary laser exclusion criteria, such as pregnancy, lactation,
haemophilic conditions, drug/alcohol abuse and significant tanning (less than 6 weeks prior to
treatment) was also applied.
 Trial design and methods
The study was a split-face comparative double-blinded study without a separate control group. It
enabled a comparison between two lasers: the KTP laser and the investigational PhotoLase laser.
The split-face design eliminated the individual biases and the randomization of the side of the face
eliminated the possible small variations in the symmetry of the telangiectases on the face. The
double-blind assessment eliminated the two investigators’ and the subjects’ subjective and
objective bias. This means that the subjects were not aware which side was treated with which
laser, and even though the two investigators also performed the treatments, their efficacy
assessments can be regarded blinded, since the before-and-after images did not show information
about which device was used in either side of the face. The subjects had 1–2 treatments
depending on the investigator’s assessment.
Both lasers were equipped with a scanner that produced a hexagon pattern and covered an area
roughly 1 cm2 in size. The KTP laser (Aura XP, Laserscope) employed Laserscope Smartscan
and PhotoLase the MedArt scanner, presented in section 5.2.2. The spot diameter was 1.0 mm in
KTP and 1.4 mm in PhotoLase.
The primary endpoints of the trial were the 7-point Telangiectasia Grading Scale (TGS) value and
self-assessment of possible adverse effects using Visual Analogue Scale (VAS) for pain and a 4-
point scale (0=absent, 1=mild, 2=moderate, 3=severe) for erythema, edema, crusting, purpura and
blisters. The TGS value assessment was performed by comparing baseline and post-treatment
split-face images after 1–2 months from the treatment. Both the subjects and the investigators
performed the TGS assessment. However, the subjects only used a mirror and their own memory
of the before-situation to give an evaluation. Whereas, the investigators performed the comparison
using the before-and-after images and made a consensus decision on the TGS value. Canfield
Visia facial imaging system was employed to ensure comparable images with standardized light
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and facial positioning. The system also offers multi-spectral images with different filters, such as
erythema-weighted images.
Assessment of adverse effects was conducted through self-assessment forms given to the
subjects. The amount of experienced pain was monitored using VAS (visual analogue scale, scale
from 0 (no pain) to 100 (worst possible pain)) and evaluated by the subjects right after each laser
treatment.  The subjects also evaluated the observed adverse effects such as erythema (redness),
oedema (swelling), purpura (bruising), crusting and blisters 48–72 hours after the treatment.
Additionally, the treating investigator assessed the adverse events right after each treatment.
 The TGS has the following scores: -1 = condition worsened; 0 = no change; 1 = some
improvement (<25%); 2 = intermediate improvement (25–50%), 3 = significant improvement (50–
75%); 4 = very significant improvement (>75%); 5 = complete resolution of telangiectasia. The
subject’s self-assessment for the adverse effects was performed immediately after each treatment
and then again after 48–72 hours. The patient flow in the trial is illustrated in Figure 5.7.
Figure 5.7. Flow chart of the trial process [P5].
5.5    Clinical Results
57
 Clinical Results
 General
Twenty-four volunteers participated in the trial, but six of them were excluded from the analysis,
because their telangiectasia could not be assessed from the Visia images. The mean age of the
remaining 18 subjects was 48 years and the gender ratio was 16 females and two males. Nine
subjects received KTP on the left cheek and PhotoLase on the right cheek, and nine subjects vice
versa. Second treatment was performed on thirteen subjects. The Fitzpatrick’s skin phototypes
were I, II or III in 6/8/4 subjects, respectively. The baseline telangiectasia grades were I, II, or III in
4/9/5 subjects, respectively, and the grades were practically symmetrical in all of the subjects.
Treatment parameters were selected to achieve the same clinical end-point of vessel
disappearance or clot formation within the vessel. This end-point was based on the subjective
perception of the two investigators, whom together have more than 27 years of experience in
treating dermatologic conditions. Double passes were performed when needed. KTP settings were
20–30 J/cm2 at 10 ms pulse duration and PhotoLase settings were 5.6–8.1 J/cm2 at 25 ms pulse
duration. The pulse duration of each device was determined by the investigators. They chose to
use a higher pulse duration for PhotoLase, since it was the minimum duration that produced the
end-point they were looking for. No topical anesthesia or cooling was used, which proved to be an
issue with PhotoLase laser.
 Efficacy
Figure 5.8 illustrates the distribution of TGS scores assessed by the subjects and the blinded
investigators after one treatment. According to the blinded investigators, fifteen subjects (83%)
had a TGS value of 3 or larger, indicating at least 50% improvement after the first PhotoLase
treatment, and a similar result was observed for KTP (p=0.29). The subjects’ assessment favoured
KTP; seven subjects had at least 50% improvement with PhotoLase after first treatment, whereas
for KTP it was 10 subjects (p-value of 0.008‡).
The subjects and the investigators also assessed the potential benefit of the second treatment.
According to the subjects, 11/13 benefited from the second KTP treatments and 10/13 from the
second PhotoLase treatment, however the difference in the treatment efficacy was statistically
insignificant (p=0.54). According to the investigators, 9/13 subjects benefited from the second KTP
‡Result is statistically significant if p < 0.05, whereas, a high p-value indicates that the result (in
this case the difference between the TGS values) is statistically insignificant.
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treatment and 8/13 from the second PhotoLase treatment. In this case also, the difference between
the devices was statistically insignificant (p=0.81).
Figure 5.8. Telangiectasia Grading Scale values assessed by the subjects (left) and the blinded
investigators (middle) after one treatment. The difference of pain between KTP and PhotoLase
treatments assessed by the subjects using the Visual Analogue Scale (0–100) is illustrated on the
right. It shows that more pain was reported with PhotoLase treatment [P5].
Figure 5.9 shows the before and after Visia images of a female subject with moderate
telangiectasia. The left side was treated with KTP laser and the right side with PhotoLase laser. In
this case, the assessed TGS values were 4 on the KTP side and 3 on the PhotoLase side after
the first treatment, and 4 in both sides after the second treatment, according to the blinded
investigators. In this case, the female subject assessed equal amount of improvement on both
sides after both treatments. Figure 5.10 also shows the erythema-weighted Visia images.
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Figure 5.9. Regular Visia images of a female subject with moderate baseline telangiectasia. More
than 75% clearance of telangiectasia was observed on both cheeks after the second treatment
[P5].
Figure 5.10. Erythema-weighted Visia images of the same female subject. Note the added benefit
of the second treatment [P5].
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 Adverse effects
The subjects evaluated that PhotoLase treatment causes more pain than the KTP treatment. The
mean VAS-value for PhotoLase was 67.6 (SD§ 22.9) and 34.6 (SD 16.9) for KTP (shown in Figure
5.8 (Right)). There was no difference in the frequency of erythema, crusting or purpura between
KTP and PhotoLase, as assessed using a 0–3 scale, 2-3 days after the treatments. More blistering
and less edema were seen after PhotoLase treatment (p < 0.05, Table 5.3). A small superficial
atrophic scar was noted in two subjects on the PhotoLase side.
Table 5.3. The frequency of adverse effects 2–3 days after the first treatment with KTP and
PhotoLase. The intensity of the reactions was scaled: 0=absent, 1=mild, 2=moderate, 3=severe
[P5].
Adverse
effect
Treatment reactions
2–3 days after KTP
treatment (%)
Treatment reactions 2–3
days after PhotoLase
treatment (%)
P-value
Erythema 0.87
0 1 (6) 2 (11)
1 7 (39) 7 (39)
2 8 (44) 6 (33)
3 2 (11) 3 (17)
Crusting 0.55
0 11 (61) 9 (50)
1 4 (22) 5 (28)
2 3 (17) 3 (17)
3 0 (0) 1 (6)
Edema 0.007
0 2 (11) 3 (17)
1 1 (6) 7 (39)
2 5 (28) 6 (33)
3 10 (56) 2 (11)
Purpura 0.12
0 11 (61) 14 (78)
1 3 (17) 3 (17)
2 1 (6) 1 (6)
3 1 (6) 0 (0)
§ Standard deviation
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Blistering 0.023
0 15 (83) 10 (56)
1 3 (17) 3 (17)
2 0 (0) 3 (17)
3 0 (0) 2 (11)
 Functionality of the yellow VECSEL system
As a secondary objective, the investigators also assessed the functionality and user-friendliness
of the yellow VESCEL system. The investigators reported that the most obvious difference
between the two laser systems was scanning speed. With KTP one scan of ~1 cm2 area took 17.5
seconds, whereas with PhotoLase less than 1 second. If we assume and average of 3 seconds
between treatment scans, this yields a 4.7-fold difference in treatment speed favouring PhotoLase.
The Smartscan scanner was also larger, bulkier and heavier. It should be noted though that the
Smartscan is older technology than the MedArt scanner and essentially both lasers could
accommodate different scanners or hand pieces after some technical and software changes. The
Smartscan scanner was operated using a button integrated in the scanning unit, whereas the
MedArt scanner was used with a foot pedal. The investigators favoured the hand-button for easier
administration of the pulses. The foot pedal employed by PhotoLase also had to be pushed very
gently in order to initiate the scanning, which we deemed to be a design fault in the commercially
bought foot pedal. In future designs of PhotoLase a more robust foot pedal is warranted. Both
laser systems were stable during the trial period and no significant malfunctions were noted, apart
from the difficulty of initiating a scan with PhotoLase foot pedal. The investigators were pleased
with the touch screen control of PhotoLase, but did not find it better or worse than the KTP-laser’s
control panel. KTP-laser was equipped with an aiming beam, whereas this feature was missing
from PhotoLase; the position of the scan pattern was only indicated by physical grooves on the
distance piece. Investigators would prefer to have an aiming beam. The investigators also thought
that PhotoLase was more compact, narrower, lighter and easier to carry compared to the
KTP-laser.
 Discussion and conclusions
The strengths of the study were the randomised split-face design, high-quality Visia images, and
excellent subject compliance. It is also, to our knowledge, the first head-to-head study that
compares a yellow (585 nm) VECSEL laser to the traditional green KTP laser in the treatment of
facial telangiectasia. No serious adverse effects were reported during the study; only two
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superficial non-permanent scars that resulted from blisters were noted on the PhotoLase sides.
The weaknesses of the study, in retrospect, were the absence of tissue cooling which prevented
the usage of higher fluences with PhotoLase, milder occurrence of facial telangiectasia on subjects,
the relatively large grading steps in the TGS grading scale and older generation KTP-laser.
Other recent studies that have utilised a yellow laser (PDL or other) in the treatment of
telangiectasia have reported higher as well as slightly lower cure rates than were achieved in our
study (50% cure rate in 83.3% of treated areas with PhotoLase or KTP). In a study by Kapicioglu
et al., the used laser parameters for a 577-nm SDL laser were a 6-mm spot size and a fluence
range of 16–22 J/cm2 [94]. The reported cure rate was 76.6% for telangiectasia after the first
treatment. In another study by Tanghetti, the used laser parameters for a 595-nm PDL (V-Star,
Cynosure) were a 10- to 40-ms pulse duration and a fluence range of 8.1–14.5 J/cm2 [95]. The
study also utilized Zimmer air cooling. About 80% of the subjects reached a 50% or higher cure
rate with 1–2 treatments. We also found another split-face study that compared a different KTP-
laser (Gemini, Laserscope) and a 595-nm PDL (Candela VBeam) in the treatment of facial
telangiectasia [96]. In the study, the PDL settings were a 10-mm spot, a fluence of 7.5 J/cm2, a
10-ms pulse duration, optional pulse stacking, and dynamic nitrogen cooling spray. The KTP
settings were mostly 10 J/cm2 at 18 ms and 9 J/cm2 at 23 ms with 5- and 10-mm spot sizes,
respectively, and a sapphire contact cooling. The cure rates were 62% with KTP, and 49% with
PDL after the first treatment.
There are probably two main reasons for the different cure rates. Firstly, more pronounced
treatment outcomes could have been obtained if the subjects in the trial had had more severe
facial telangiectasia. However, our trial was conducted in the private sector, where typically also
milder presentations of telangiectasia are treated compared to hospital conditions. Secondly, we
did not use any cooling or topical anaesthesia to prevent possible vasoconstriction in the treatment
area. The pain experienced by the subjects limited the use of higher fluences with PhotoLase,
which is capable of producing fluences up to 52 J/cm2. This pain could be alleviated with a tissue
cooling device allowing us to use higher fluences (such as in other studies), which can be expected
to lead even better clinical outcomes. To this end, a tissue cooling device will be added to the next
design of the system and we will also consider increasing the spot size. In addition, two other
technical issues will be addressed in the next design: missing aiming beam and the troublesome
foot pedal.
Moreover, the third weakness arises from the insensitivity of the TGS assessment tool. We believe
it explains the discrepancy in the subjects’ and the investigators’ assessment. Subjects might
easily give different TGS scores, if they notice even a slight difference in the erythema between
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face sides. Experienced clinicians, then again, will not let too small differences distract the overall
assessment. In addition, the subjects’ assessment was based on their memory, whereas the
blinded investigators had high-quality standard and erythema-weighted images to compare the
results very systematically. Finally, we acknowledge that the present study would be stronger, if
the PhotoLase system had been compared to a modern PDL or large spot size KTP. The
functionality and speed of modern devices are on a different level than that of Aura XP with
SmartScan. Newer KTP devices with large spot size can also treat telangiectases with lower
fluencies due to deeper penetration and even distribution of energy, reducing the cooling effect of
blood flow [97]. On the other hand, we still considered it fair to compare the clinical outcome of the
present devices, since the scanning patterns were similar and the spots sizes were close to each
other in terms of diameter.
In conclusion, the yellow VESCEL system PhotoLase produced similar clinical outcome as the
traditional green KTP laser. A major benefit of the PhotoLase system is the significant decrease
of treatment time, which could be even further decreased by enlarging the scanning area for single
illumination. The main downfall was the higher pain experienced by the subjects, which can be
addressed with integrated tissue cooling. According to the investigators, the PhotoLase system
can also be considered more user-friendly in the present setting. However, larger studies with
optimized cooling and laser parameters are warranted to gain evidence of superiority compared
to other systems. To this end, we are designing a clinical study in cooperation with INSERM and
Lille Hospital (France) to be commenced in the following months. It will also be a split-face study
comparing PhotoLase and KTP laser in the treatment of facial telangiectasia. The main differences
to the already performed trial are the hospital setting (most likely subjects have more severe
telangiectasia), the addition of a tissue cooling device (which will enable to use higher fluences
with PhotoLase), larger subject group and newer KTP laser (Excel V, Cutera).
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6 Conclusions
Chapter 6
Conclusions
The general objective of this thesis was to develop VECSELs at challenging wavelengths, which
was fulfilled by demonstrating 20 W at 588 nm, 10 W at 615 nm and 72 W at 1178 nm. The main
characteristics and results from these VECSELs are listed in Table 6.1. More specifically, the goal
was to proof the potential of VECSEL-technology in medical applications. This was achieved by
developing a yellow VECSEL system designed to be used in the treatment of vessel-related skin
conditions, such as dilated blood vessels (telangiectasia). The system produces continuous wave
yellow emission up to 8 W at a wavelength of 585 ± 5 nm. It is equipped with a handheld scanner
that delivers the laser light onto skin in a desired pattern. The most important treatment parameters,
fluence and pulse duration, are adjustable from the touch-screen display.
The yellow VECSEL system was tested as part of a clinical trial, which compared the efficacy of
the new system to the traditional green KTP laser in the treatment of facial telangiectasia.
According to the trial, there was no statistically significant difference between the efficacies of the
two lasers. Over 50% cure rate was achieved with the yellow VECSEL system in 83% of the
treatment areas after first treatment, and even better results were seen after two treatments. A
benefit of the yellow VECSEL system was fast scanning of treatment areas provided by the
scanner technology. Treatments were somewhat more painful with the yellow laser, but this could
be addressed by integrating a cooling device to the system and will be tested as part of another
clinical trial. No serious adverse effects were reported during the trial and the clinical investigators
reported that they considered the yellow VECSEL system to be user-friendly, but would prefer to
have an aiming beam and a button for light-activation rather than a foot pedal.
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Table 6.1. Summary of results from the laboratory set-up VECSELs in this thesis.
Wavelength
(nm)
Doubling
crystal
Operation
mode
Output
power
(W)
Heatsink
temp.
(°C)
FWHM
(nm)
Opt.-to-opt.
conversion
efficiency
588 NCPM LBO CW 20.0 8.3 0.2 27%
588 CPM LBO CW 8.5 20 15%
588 CPM LBO Pulsed,
~1 µs
14.1
(peak)
20 0.1 21%
615 NCPM LBO CW 10.5 8 0.4 17.5%
615 NCPM LBO CW 8.0 20
615 NCPM LBO Pulsed,
~1 µs
13.8
(peak)
20 0.1 20.4%
1180 CW 72 0 5.5 29%
1178 CW 19 20 0.06 14%
 Prospective medical applications of VECSELs
VECSEL technology is quite mature. It has already entered the laser market providing compact
solutions at various wavelengths for a wide range of applications. However, there are still some
gaps in the wavelength coverage especially for high-power and single-frequency emission,
particularly in the visible and UV spectral range. With further material development, efficient
frequency-conversion configurations and careful cavity architecture design, VECSELs could offer
tailored solution for existing applications and pave the way for new ones.
One of the main application areas for lasers is medicine. In Table 6.2, we make a modest attempt
to review several medical and life science applications of lasers and discuss their requirements
from the perspective of the current achievements of VECSEL technology.
Table 6.2. A prospective list of medical and other life science applications where VECSELs could
be used.
Application Short description & laser specifications What VECSELs can offer
Eye surgery
and retinal
laser therapy
Laser light is used to coagulate blood vessels
e.g. to seal tears, which can lower the risk of
vision loss in various eye diseases.
 577 nm (haemoglobin absorption)
VECSELs have a compact footprint
and are more affordable than e.g.
PDLs. Emission at 577 nm with a good
beam quality and several watts of
Chapter 6. Conclusions
66
 Pulsed operation with ~1 µs pulse, also
few tens of milliseconds have been used.
The risk of ruptures increases as pulse length
decreases. Peak powers of ~2 W have been
utilized [98].
output power can be achieved via
intracavity frequency doubling.
Microsecond pulses have been
obtained by directly modulating the
pump laser [P1]. Yellow diode lasers
producing microsecond pulses are also
available and have proved to be
effective in retinal therapy [99].
Photodynamic
Therapy (PDT)
Laser light is used to activate a
photosensitizer to cause a photochemical
process that creates free radicals and
destroys targeted cells [100]. Routinely used
in cancer therapy [101].
 Laser wavelength is dependent on the
photosensitizer’s absorption spectrum.
Typically, photosensitizers have
absorption peaks within 630–740 nm
range.
 Both CW and pulsed operation are used.
VECSELs can easily produce high-
power red light via frequency doubling
[102]. The wavelength versatility and
broad tuning range of VECSELs could
provide important benefits for dealing
with a wider range of photosensitizers
while employing only one laser system.
On the other hand, the needs in terms
of power level and brightness are met
by simpler laser diode technology,
whenever available for a certain
wavelength.
Selective
Photothermoly
sis (PT)
Laser light is directed to a certain tissue
target, e.g. a blood vessel. The target
absorbs the light producing enough heat to
cause controlled damage. Often used to treat
cutaneous vascular diseases such as PWSs
[103], and PT is also the method behind
tattoo removal.
 577 nm (haemoglobin absorption), 585–
595 for deeper penetration.
 Pulsed operation with few ms pulses to
avoid unwanted damage [103, 104].
The preferred yellow emission is
already available as a commercial
VECSEL product (Genesis Taipan 577
commercialized by Coherent, delivers
multi-watt output power [105]). Longer
yellow wavelengths are demonstrated
in this thesis and integrated into a laser
system designed for medical use. In
addition, medical laser company
Asclepion has designed a table-top
yellow laser for dermatology based on
semiconductor laser technology [106].
Photoacoustics
(PA)
Imaging method in which laser light is
absorbed by tissue causing it to heat up. This
temperature change induces sound waves
which can be detected to form an image
[107].
 Pulsed NIR lasers (1064 nm) are often
used for deeper penetration, but visible
wavelengths can be better for more
targeted absorption.
 Pulse duration is in the nanosecond range,
repetition rate in tens of Hz and typical
pulse energy is a few tens of mJ [108].
The development of VECSEL
technology continuously aims for
higher power and shorter pulses.
However, we should note that unlike
with the solid-state systems the fast
carrier dynamics in VECSEL gain
mirrors does not allow for energy
accumulation between pulses. Cavity
damping schemes have led to the
generation of ns pulses with peak
powers of 57 W [109].
Stimulated
Emission
Depletion
Aims at microscopy imaging on a smaller
scale than the diffraction limit. Two laser
beams are overlapped; the first laser beam
VECSELs are power scalable and they
can emit continuous yellow-orange
radiation and be wavelength tuned to
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(STED)
Microscopy
excites fluorophores in a sample and the
second depletes fluorescence around the
excited spot through stimulated emission.
 Absorption spectrum of the fluorophores
determines the laser wavelength.
Common green and yellow fluorescent
proteins require excitation with blue laser
and depletion with yellow/orange laser
(~560–600 nm).
 Both lasers can be pulsed (picosecond
range) or the depleting laser can be CW
for simplicity and lower cost.
 Few hundred mW of CW power is needed
on the sample which translates to a few W
of laser power [110].
match a fluorophore’s absorption peak.
Therefore, they would be suitable to
operate as the depletion laser in STED
microscopy. Other advantages are low
cost for a high-power source, small
footprint and reliability.  Preliminary
experiments were performed using a
yellow VECSEL as the depleting laser
in collaboration with UCL during this
thesis work [111].
Flow Cytometry Cells (or other particles) are passed through
laser light one at a time and the resulting
forward scatter, side scatter and
fluorescence light are collected by detectors
and analysed to determine multiple
characteristics of cells [112, 113].
 Several visible wavelengths are required
e.g. blue, green, yellow and red.
 Tens of mW of CW output power is
sufficient and
VECSELs can reach the visible
spectrum via frequency doubling and a
power scale of tens of mW is easily
achievable. A possible advantageous
feature is the relatively broad tuning
range (~10–20 nm) for visible
wavelengths. Diode and solid state
lasers can also offer low-cost average
power emission in the visible range.
NIR Laser
Surgery
Laser light is absorbed to an extent that it
vaporizes tissue leading to tissue ablation.
The advantage over a conventional scalpel is
that, since it is a thermal effect, the laser cut
tissue is burnt and hence less bleeding
occurs. Can be used to e.g. remove
cancerous [114] tissue or resurface skin.
 Water absorbs light increasingly from
about 800 nm until 11 µm and there is a
high peak around 2.9 µm [115]. Hence, IR
lasers are optimal for tissue ablation.
 High-power, usually pulsed, lasers are
needed.
VECSELs emitting at 2 µm are mature.
Power-wise they cannot yet match the
currently used lasers in NIR laser
surgery (such as Er:YAG laser and
CO2), but average power in the range
of 10 W could already be used in
nano-surgery. Main advantages over
solid-state systems are compactness
and overall simple solution.
Multiphoton
microsocpy
Based on nonlinear excitation in which light
effect is confined to a volume smaller than in
the case of one-photon fluorescence. This
provides benefits in terms of phototoxicity and
allows optical sectioning of the sample with
3D reconstruction [116].
 NIR/IR laser preferred for deep
penetration, low scattering and lower
Modelocked VECSELs possess high
repetition rate  (1 GHz range) providing
better factor of merit with lower average
power, and their wavelength can be
tailored to match a wide range of
targets [117, 118]. In addition, they
exhibit a high amplitude stability and
are potentially lower cost systems
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phototoxicity, but laser wavelength
dependent on fluorophore’s absorption.
 Ultrashort pulse duration (femtosecond
range) necessary. Low power is sufficient
(milliwatt range).
compared to established ultrafast solid
state lasers.
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Abstract: A high-efficiency optically pumped vertical-external-cavity
surface-emitting laser emitting 20 W at a wavelength around 588 nm is
demonstrated. The semiconductor gain chip emitted at a fundamental
wavelength around 1170-1180 nm and the laser employed a V-shaped cavity.
The yellow spectral range was achieved by intra-cavity frequency doubling
using a LBO crystal. The laser could be tuned over a bandwidth of ~26 nm
while exhibiting watt-level output powers. The maximum conversion
efficiency from absorbed pump power to yellow output was 28 % for
continuous wave operation. The VECSEL’s output could be modulated to
generate optical pulses with duration down to 570 ns by directly modulating
the pump laser. The high-power pulse operation is a key feature for
astrophysics and medical applications while at the same time enables higher
slope efficiency than continuous wave operation owing to decreased heating.
© 2014 Optical Society of America
OCIS codes: (140.3460) Lasers; (140.3480) Lasers, diode-pumped; (140.3515) Lasers, frequency
doubled; (140.3538) Lasers, pulsed; (140.3600) Lasers, tunable; (140.5960) Semiconductor
lasers.
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1. Introduction
Practical and cost-effective yellow lasers are needed in many important medical applications
including dermatology, eye surgery and novel imaging methods. In these applications, overall
results can be improved, damage to healthy tissue decreased, or resolution increased by
implementing a laser that can be tuned to a preferred wavelength and work in pulsed operation
instead of continuous wave [1-3]. The yellow spectral range is particularly interesting in
medicine due to increased interaction with hemoglobin in blood, which has high absorption
peaks in this range. In addition, some of the most common fluorescent markers often used in
fluorescence based medical imaging have their depletion wavelength in the yellow range [3]. For
medical applications pulsed operation is often preferred due to increased efficiency and
decreased damage to healthy tissue; for example in photocoagulation based eye surgery the ideal
pulse width is in the order of 1 µs [4]. Furthermore, the availability of reliable yellow lasers able
to operate in pulsed mode would impact scientific application areas, such as astronomy, where
lasers emitting narrow linewidth at the sodium absorption line (589nm) can be used to create a
laser guide star for earth-based telescopes [5].
The yellow spectral range cannot be reached via direct emission from semiconductor lasers,
which is the preferred laser technology when taking into account compactness, cost, efficiency,
reliability, and wavelength coverage. The shortest wavelength in the orange region recently
demonstrated for direct emission is 599 nm yet the efficiency of the GaInP material system used
in this case is rather modest [6]. Alternative yellow laser solutions make use of amplification and
frequency conversion in solid-state systems [7] but the complexity, price, and often their
limitations in power and wavelength coverage, render them unsuitable for a wide exploitation.
A much more attractive path to generate yellow radiation has emerged with the development of
vertical-external-cavity surface-emitting lasers (VECSELs), also known as semiconductor disk
lasers (SDLs) [8]. These are compact, power scalable laser sources that are able to maintain good
beam quality even when emitting output powers in excess of several watts to several tens of
watts [9,10]. Owing to the wavelength versatility of semiconductor gain region they can cover
an extremely large emission spectrum by direct emission from 670 nm up to 5000 nm [11-14],
yet not without gaps, and can be tuned over tens of nanometers [15,16]. Moreover, unlike the
solid state disk lasers, owing to the lower carrier lifetimes the output of VECSELs/SDLs can be
modulated on a time scale of a few hundreds of nanosecond by directly modulating the pump
laser that at the same time can alleviate the need for advanced cooling [17]. VECSELs emitting
in the 1140-1260 nm range can be efficiently converted to yellow region using intra-cavity
nonlinear crystals [18] however their output powers and their conversion efficiency has been
rather modest compared to VECSELs operating at 1064/532 nm. This is to large extent due to
the fact that longer wavelength gain regions bring more challenges compared to standard
InGaAs/GaAs gain mirrors used for 960-1060 nm window.
In this article, we demonstrated a frequency doubled yellow VECSEL emitting 20 W output
power with moderate cooling. The measured output power is an improvement of over 12 W over
the previously reported yellow VECSEL [18]. Furthermore, the conversion efficiency from
absorbed pump power to yellow output power has been improved from 17 % to 28 %. For
GaInAs QW gain material the previous state of the art results were 5 W of 589 nm radiation with
~16 % conversion efficiency [19]. Frequency doubled yellow radiation has also been
demonstrated with QDs, but with significantly lower output power and even lower efficiency
(~5 %) compared to QW structures [20].
Besides the CW operation, we have also implemented a pulse modulation scheme using direct
modulation of the pump lasers. The demonstrated pulse duration in the range of 1µs is a good fit
to requirements pertinent to medical and guide star applications. Even if the pulse duration is
rather long, it could still ease the thermal load and provided further means to increase the power
and improve the overall system efficiency.
2. Experimental setup
The semiconductor gain mirror was grown by molecular beam epitaxy (MBE) with an active
region that incorporated 10 GaInAs/GaAs/GaAsP quantum wells grown on top of a 25.5-pair
AlAs/GaAs distributed Bragg reflector (DBR). The structure is illustrated in a more detailed
manner in Fig. 1. The gain structure was designed to be anti-resonant at 1180 nm. For efficient
thermal management, the gain mirror was diced into 2.5 mm x 2.5 mm chips that were capillary
bonded to a wedged (2°) intra-cavity CVD diamond heat spreader, which was attached to a
water-cooled copper mount with indium foil. The outer surface of the heat spreader was
antireflection coated for the designed 1180 nm emission. The operation of the gain material at
the fundamental wavelength has already been tested and the results were published in [12]. A
maximum output power of 23 W at ~1180 nm was obtained with a 97 % reflecting output
coupler.
Fig. 1. Schematic illustration of the semiconductor layer structure.
The VECSEL cavity was formed by the gain mirror, a folding mirror (RoC = 75 mm) and a
flat end mirror in a V-shaped configuration with the first arm having a length of 102 mm and the
second 47 mm. A 1.5 mm thick birefringent filter (BRF) and a 100 µm thick etalon were placed
along the first arm of the cavity to achieve wavelength tuning and linewidth narrowing. For
efficient second harmonic generation, a 10 mm non-critically phase matched lithium triborate
crystal (NCPM LBO) (and later a 10 mm critically phase matched (CPM) LBO crystal) was
inserted near the flat end mirror where the mode waist was situated. The crystal facets were flat
and had an antireflection coating for the fundamental as well as for the yellow radiation. Phase
matching was achieved via temperature tuning the crystal with a TEC operated copper oven. The
cavity configuration is shown in Fig. 2.
Fig. 2. Schematic illustration of the frequency doubled VECSEL.
All the cavity mirrors were highly reflective for the fundamental radiation. The flat end
mirror was also highly reflective for the yellow radiation, however the folding mirror was highly
transmissive (R < 5%) for the yellow radiation. Hence the yellow radiation was extracted through
it. For the CW experiments, the gain mirror was pumped with a 200 W 808 nm diode laser with
a focused spot diameter of about 510 µm. The mode diameter on the gain mirror was
approximately 400 µm and inside the LBO crystal it was 230-164 µm. For the pulse modulation
we used a lower power pump that could be driven up to peak powers of 71 W by current pulses
with amplitudes of ~50 A and pulse durations in the range of 1 µs.
3. High power CW operation
At first, the laser was tested for high power continuous wave yellow output. Several etalon and
BRF configurations with varying thicknesses were tested in order to find the optimal pair for
stable high power operation, which lead to the selection of 1.5 mm thick BRF and 100 µm thick
etalon. We also tested a critically phase matched (CPM) LBO, however the highest power was
obtained with the NCPM LBO. For the high power operation measurement the mount
temperature was estimated to be in the range of 5 to 8°C. The temperature of crystal oven was
set to 38.3 °C; this was optimized according to the emission wavelength of the VECSEL to
satisfy the phase matching condition for efficient frequency doubling. The power conversion
graph generated from the measured laser output is shown in Fig. 3 (a). A maximum of 20 W of
frequency doubled output power was measured for absorbed pump power of about 75 W, which
was obtained by subtracting measured reflected pump power (5.13 % of incident power) from
the incident pump power. The mount temperature at the maximum output power was 8.3 °C. The
mount temperature was measured next to the gain chip. The maximum conversion efficiency
(absorbed pump power to yellow output) of ~28 % was achieved at 16 W of output power, which
is an improvement of 11 percentage points compared to state of the art yellow VECSEL results
reported so far [18].
The emission spectrum of the VECSEL, set by the etalon (FSR ~5 nm, bandwidth ~0.37 nm),
was centered at 588.1 nm with a linewidth (FWHM) of <0.2 nm, shown in Fig. 3 (b). The beam
profile for the yellow radiation was preserved circular, with some distortions, as shown as inset
in Fig. 3 (a), through the measurement range. We did a separate measurement for the output
beam quality corresponding to 10 W (power level available at the time of measurement due to
NCPM LBO crystal degradation, see next page) of output power. The obtained M2 value was <
1.5 in horizontal and vertical directions. A scanning Fabry-Pérot interferometer was used to
measure the mode spectrum for the fundamental wavelength. When the laser was tuned to 589
nm, single-wavelength operation was observed for yellow output power of ~10 W, but the
operation was unstable.
Fig. 3. (a) Output power curve for yellow emission. Inset: Beam profile recorded at maximum
power. (b) Yellow spectrum measured at the maximum output power.
Next, the 1.5 mm BRF (placed at Brewster’s angle) was rotated around an axis normal to its
surface in order to test the tunability of the VECSEL.  For this experiment the absorbed pump
power was kept constant at 55 W. The corresponding mount temperatures for the chosen
absorbed pump power ranged between 9.2 and 13.5 °C depending on the emission wavelength;
the temperature increased towards the edges of the tuning bandwidth due to the reduced gain
chip efficiency and consequent increased heat generation. The temperature of the crystal oven
was optimized for each wavelength separately. This proved to be challenging because the crystal
temperature change was large enough to cause the output power to fluctuate. The 100 µm etalon
was taken out each time before the emission wavelength was tuned by rotating the BRF in order
to avoid a wavelength jump determined by the FSR of the etalon, and put back in for linewidth
narrowing after the laser was tuned to a chosen wavelength.
The tuning spectrum is presented in Fig. 4 with each line having a full width half maximum
of ~0.2 nm. The highest output power (15 W) was obtained for emission wavelength of about
588 nm. The tuning bandwidth was ~26 nm ranging from about 576 to 602 nm.
Fig. 4. Spectrum and yellow output power measured at each wavelength tuning point. The spectra
curves are rescaled to equal height in order to better reveal their shape for a better comparison.
The output power for each wavelength can be read from the right y-axis.
To test the operation at higher temperatures, power curves for different gain mirror mount
temperatures were measured. The same cavity configuration was used as described earlier except
the nonlinear crystal was changed from 10 mm NCMP LBO to a 10 mm CPM LBO. The change
was made, because significant deterioration was observed in the NCPM LBO crystal
performance during the course of the experiments and a suitable replacement was not available.
We believe the crystal degradation was caused by damaged AR coatings on the facets of the
NCPM LBO, which was obvious as observed with an optical microscope. The temperature of
the CPM LBO was stabilized with the same copper oven that was used for phase matching with
the NCPM LBO. The temperature stabilization was necessary because the stray light of the laser,
arising from the parasitic reflections of the gain chip and the BRF, and the pump would have
otherwise heated the copper oven of the crystal, and consequently, the crystal above its phase
matching temperature (room temperature). The oven temperature was kept constant at 23.1 °C
and efficient phase matching was achieved by having the CPM LBO critically cut for type I SHG
at 1178 nm and having control of the significant crystal tilts.
Fig. 5. Evolution of the mount temperature as a function of the absorbed pump power.
The power curves were measured for coolant temperatures of 0, 10, 20 and 30 °C, which
corresponded to mount temperatures of 4.5-12.8, 13.9-22.1, 22.9-31.2 and 32.2-38.7 °C,
respectively. The dependence of the mount temperature on the absorbed pump power is
presented in Fig. 5, which shows that the heat load generated by the increasing pump power led
to an increase in the mount temperature of the gain mirror. Whereas, the resulting output power
for each temperature setting against absorbed pump power is plotted in Fig. 6. We could not
achieve the 20 W of output power that was obtained with the NCPM LBO, because of the CPM
LBO crystal properties. The two crystals were ordered from different manufacturers, which can
already cause a difference of several Watts in the output as observed while testing two NCPM
LBOs from different manufacturers with same specifications. In addition, NCPM LBO is
expected to yield higher efficiency because it does not suffer from the phenomena of spatial
walk-off and is less sensitive to a slight misalignment of the beams. Furthermore, the acceptance
angle of the CPM LBO is smaller than that of the NCPM LBO, which could have an impact on
the conversion efficiency. The highest output power of 14.6 W was achieved for lowest mount
temperature as expected due to the better luminous efficiency of the semiconductor material as
the temperature is decreased. Similarly, the output power is expected to drop for the higher mount
temperatures, as is observable from Fig. 6. However, for lower pump powers, the output power
was higher for some elevated mount temperatures, which can be seen as overlapping of curves
in Fig. 6. This phenomenon was most likely caused by better alignment of the laser wavelength
with the gain and with the CPM LBO crystal phase matching condition.
Fig. 6. Output power characteristics for different gain mirror mount temperatures. Insets: Beam
profiles recorded at each maximum output power.
4. Pulsed operation
Heating of the gain chip structure by the incident pump power causes thermal rollover and clearly
limits the CW operation, as can be seen from the above power curves. In order to overcome the
thermal effects and improve conversion efficiency the yellow laser was tested in pulsed mode.
The same cavity configuration was used as for the elevated mount temperature experiments, but
a pulsed laser was employed for pumping. The LBO crystal temperature was kept near room
temperature and the chip mount temperature was measured to be 21 °C throughout the
measurements. The pump laser was driven with a driver capable of producing pulse widths up
to ~1.5 µs. Two Si biased detectors were used to monitor the light pulses generated by the pump
laser and the VECSEL.  The pulse waveforms for the pump laser, as well as the yellow output at
the maximum operation of the pump laser, are shown in Fig. 7. The respective FWHM pulse
widths are 1.64 µs and 1.08 µs. A time delay of 0.66 µs was measured between the pump pulse
and the yellow pulse. The reason for the delay is not clear. We suspected that the time delay
could be caused by the need for the gain chip to heat up and consequently reach sufficiently low
detuning for lasing. However, the delay did not change even when the coolant water temperature
was raised to 60 C as would have been expected based on the assumption. This implies that the
heating of the gain chip does not play a noticeable role in the pulse on-set delay.
Fig. 7. Pulse shapes for the pump laser driver (black trace), pump laser output (red) and VECSEL
output (blue) recorded at maximum pump laser operation for 1.5 µs pulse width setting.
For comparison, power curves for two different pulse widths were measured. First the driver
was set to produce 1.5 µs pulses and then to 1.0 µs. The repetition rate was kept at 10 kHz. The
peak power of the pulses was calculated by measuring the average power of the output and
FWHM pulse width of the pulse waveforms. The peak power measurements for the two different
pulse widths are shown in Fig. 8 (a). The CW power curve (average power) is also shown in Fig.
8 (a) for comparison. It can be clearly seen that in pulsed operation higher powers can be
achieved due to decreased heating of the semiconductor gain chip. The CW operation shows
thermal rollover at around 60 W of absorbed pump power, but the pulsed operation shows a
linearly increasing trend, limited by the available peak pump power. Furthermore, the optical-
to-optical conversion efficiency of the CW operation at maximum output power was 14 %
whereas for the pulsed operation the conversion efficiencies were 20 % and 21 %, for the 1.08
µs and 0.57 µs pulses respectively. The maximum average output power measured for CW
operation was 8.5 W and the maximum peak power measured in the pulsed mode was 14.1 W
for the 0.57 µs pulse width and 13.8 W for the longer, 1.08 µs pulse width. The maximum average
output powers for the pulsed operation were 81 mW and 149 mW, respectively. The pulse width
was limited by the long rise time of the driver; at shorter pulse widths the current was cut which
decreased the peak pump power. Yellow spectrum for the 0.57 µs pulse is shown in Fig. 8 (b).
Fig. 8. (a) Output power characteristics for 20 °C (mount temperature of gain mirror) continuous
wave (average power) and pulsed operation (peak power) at two different pulse width settings. (b)
Output spectrum measured for pulsed operation for 0.57 µs pulse width.
5. Conclusions
High-power efficient operation of a frequency doubled yellow VECSEL has been demonstrated
for both CW and pulsed operation. The maximum yellow output power achieved was 20 W for
75 W of absorbed pump power, which yielded an optical-to-optical conversion efficiency of 27
%. The maximum conversion of 28 % was achieved with a slightly lower output power of 16 W.
Wavelength selective components inside the laser cavity allowed to narrow the emission
linewidth and tune the operation wavelength of the laser; a tuning bandwidth of ~26 nm was
measured. A further narrowing of the linewidth into single longitudinal operation with a different
choice of etalon would make the laser suitable for guide star application. During the high power
measurements, the VECSEL operated also in single wavelength at 589 nm with ~10 W of output
power. However, the operation was unstable.
The operation of the laser was also tested at different gain mirror mount temperatures using
another, critically phase matched (CPM) LBO crystal. At mount temperature of 12.8 °C the
maximum output power achieved was about 15 W, whereas for the highest temperature, 38.7 °C,
it was 7 W. The high power operation even at elevated temperature makes it more attractive for
implementation into medical equipment, since it will not require high cooling capacity.
The same CPM LBO was used during pulsed operation, where the thermal effects were
reduced so that a thermal rollover was not apparent for the available maximum pump power. The
maximum output powers achieved with pulse widths of 0.57 and 1.08 µs were 14.1 and 13.8 W
respectively, compared to the CW maximum of 8.5 W in this setup. The power curves for the
pulsed operation suggest that even higher powers can be achieved for higher peak pump powers.
The pulse widths were limited by the modulation capability of the electronics and pump system
time, but the ~1 µs long pulses are already suitable for certain medical application e.g. eye
surgery.
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Abstract: A high-power optically-pumped vertical-external-cavity surface-
emitting laser (VECSEL) generating 10.5 W of cw output power at 615 nm
is reported. The gain mirror incorporated 10 GaInNAs quantum wells and
was designed to have an emission peak in the 1230 nm range. The
fundamental emission was frequency doubled to the red spectral range by
using an intra-cavity nonlinear LBO crystal. The maximum optical-to-
optical conversion efficiency was 17.5%. The VECSEL was also operated
in pulsed mode by directly modulating the pump laser to produce light
pulses with duration of ~1.5 µs. The maximum peak power for pulsed
operation (pump limited) was 13.8 W. This corresponded to an optical-to-
optical conversion efficiency of 20.4%.
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1. Introduction
High-power red lasers are useful for many applications, including laser projection,
spectroscopy and medicine. For example, there is an increasing need for single-frequency
high-brightness lasers emitting in the long visible wavelength range for quantum optics
applications [1,2]. In addition, laser projection relies on lasers emitting >10 W of red, green
and blue light. Currently, laser diodes emitting around 640 nm are used as the red light
sources in display technology [3]. However, the human eye is more sensitive to shorter red
wavelengths, therefore a laser emitting closer to 620 nm would allow higher lumen efficacy.
Decreasing the wavelength of laser diodes below 640 nm has proved difficult and would result
in severe power and lifetime limitations [4], hence other light sources should be considered.
Frequency doubled vertical-external-cavity surface-emitting lasers (VECSELs) have
emerged as compact and wavelength versatile laser platforms generating high-brightness
radiation in the visible wavelength range [5,6]. Their external cavity enables efficient
frequency conversion by placing a nonlinear crystal inside the laser cavity and thus allows the
exploitation of the high intra-cavity field. Furthermore, wavelength selective components (e.g.
birefringent filters and etalons) can also be added inside the cavity for narrowing the spectral
linewidth and achieving single-frequency operation [7]. Frequency doubled VECSELs have
already been extensively reported in the green spectral range [8,9] and high powers have also
been demonstrated in the yellow-orange range [10]. However, there are only a few reports on
the red spectral range, 610–630 nm, due to the difficulty associated with semiconductor
material fabrication for direct emission, as well as for frequency doubled emission. The
highest power reported for an AlGaInP quantum well gain mirror is 1.2 W with direct
emission at a longer wavelength of 665 nm [11]. GaInAs material system is a good candidate
for frequency doubled VECSELs at the shorter visible wavelength range, but it suffers from
high lattice strain at wavelengths longer than 1100 nm. This makes it difficult to grow
quantum wells emitting in the 1220–1260 nm range needed for frequency doubling to 610–
630 nm.
Using semiconductor gain mirrors based on GaInNAs, a wavelength emission range
covering 1.1 µm to 1.5 µm can be achieved [12,13]. Compared to GaInAs material systems,
the addition of nitrogen decreases the lattice strain, as well as the band gap, enabling the
fabrication of gain mirrors at longer wavelengths. So far, most of the efforts on developing
GaInNAs-based VECSELS have been focused on demonstrating fundamental emission at
1180 nm and subsequent doubling to 590 nm with power levels above 10 W [14]. In contrast,
the developments of red VECSELs based on GaInNAs gain mirrors have been scarce with the
best reported power being 4.6 W at 610 nm [15].
In this article, we report on achieving output power of more than 10 W for a red
frequency doubled continuous wave (cw) VECSEL utilizing GaInNAs quantum wells. We
also report pulsed operation of such VECSEL by directly modulating the pump laser. High
peak power operation with lower average power would especially benefit medical
applications, because damage to healthy tissue can be decreased by decreasing the average
power and thus the thermal load on the tissue.
2. Gain mirror design and fabrication
The gain mirror wafer was grown by molecular beam epitaxy on a GaAs substrate. The gain
mirror structure was designed to be resonant at 1230 nm and comprised 10 GaInNAs quantum
wells (QWs) surrounded by GaAs barrier layers. The QWs were located at the anti-nodes of
the standing optical wave formed inside the active region (see Fig. 1 for an illustration of the
structure). The thickness of a QW was 7 nm and the corresponding In and N compositions
were 31% and 0.5%, respectively. A 50-nm-thick GaInP window layer terminated the active
region and served as a carrier barrier layer preventing surface recombination. Clustering
within the QW layers was limited by using a growth temperature of 375 °C. After the growth,
the wafer was annealed for 4 minutes at ~700 °C to improve the material quality and diced
into 3 x 3 mm2 chips. For efficient heat extraction, the gain chip was capillary bonded to a
300-µm-thick CVD diamond heat spreader. The diamond was nominally flat, but it became
apparent during measurements that the surfaces were not parallel causing beam distortion.
Furthermore, the diamond was attached to a liquid-cooled copper mount via indium foil. The
outer surface of the diamond was coated with an anti-reflective coating for the pump radiation
(808 nm) and the fundamental lasing wavelength (1230 nm).
Fig. 1. Schematic illustration of the active region of the gain chip. The In and N compositions
were x ~ 35% and y ~ 0.5%, respectively.
3. Laser characterization
3.1 Experimental setup
The VECSEL was built into a V-shaped configuration formed by the gain mirror and two
curved dielectric mirrors (external mirrors), as shown in Fig. 2. The folding mirror had a
radius of curvature (RoC) of 50 mm and the cavity end mirror had a RoC of 25 mm. The gain
mirror was optically pumped using an 808 nm diode laser delivering a maximum cw power of
~120 W. The pump radiation was focused to a ~400 µm diameter spot (1/e2) on the gain
mirror using a 200-µm fiber and converging lenses. The total length of the cavity was
~147 mm with the first arm having a length of 89 mm. The mode diameter on the gain mirror
was 240 µm tangential and 300 µm sagittal. The elliptical shape of the mode was a straight
consequence of the ~30° folding angle of the V-shaped cavity.
For efficient intra-cavity frequency doubling, both external cavity mirrors need to be
highly reflective (HR) for the fundamental lasing wavelength of 1230 nm. We measured the
infrared transmittance of the HR cavity end-mirror (RoC = 25 mm) in order to determine the
intra-cavity power. For this measurement, the VECSEL cavity incorporated a HR folding
mirror and a partially reflective mirror (output coupler) as the cavity end-mirror. The HR
cavity end-mirror (also HR for the red spectral range) was then placed in front of the
VECSEL’s output beam.  A power head meter was used to measure the output power through
the HR mirror as well as when the HR mirror was removed from the beam path. The
percentage of infrared radiation transmitted through the HR mirror was calculated by dividing
the measured power readings. The transmittance of the mirror is wavelength sensitive; hence,
this process was repeated for several wavelengths around 1230 nm. The VECSEL was
wavelength tuned by placing a 1.0-mm-thick birefringent filter inside the cavity (see Fig. 2 for
a detailed illustration of the cavity setup). The transmittance of the long-wave-pass filter (used
to filter red radiation leaking through the HR cavity end-mirror) was measured in a similar
way. The transmittances of these optical components as a function of wavelength are shown in
Fig. 3.
Fig. 2. Illustration of the VECSEL configuration used for measuring the transmittance of the
HR cavity end-mirror and long-wave-pass filter (  > 900 nm). The HR cavity end-mirror is
represented by the mirror inside the dashed box and is not part of the VECSEL cavity.
Fig. 3. Transmittance of the HR cavity end-mirror, Tmirror, and the long-wave-pass filter, Tfilter ,
(  > 900 nm) as a function of wavelength.
For frequency doubling measurements, the output coupler in Fig. 2 was replaced by the HR
mirror which was characterized as illustrated in Fig. 3. In addition, a 100-µm-thick etalon was
added to the cavity for linewidth narrowing and wavelength control, and the 1.0-mm-thick
BRF was kept in place for the same reason. The red spectral range was achieved by inserting a
nonlinear lithium triborate (LBO) crystal inside the cavity, near the mode waist (~70–80 µm
in diameter). The crystal was 10 mm long and specified for Type I second harmonic
generation (SHG) cut for non-critical phase matching (NCPM). Phase matching is vital for
efficient frequency conversion and it was achieved by temperature stabilizing the crystal with
a copper oven to a temperature optimized for frequency doubling at 1230 nm. This was
achieved by observing the frequency doubled output power while changing the temperature of
the crystal’s oven. The temperature that resulted in the highest output power was 20.1 °C.
The frequency doubled radiation was extracted from the cavity through the folding mirror,
which was highly reflecting for the fundamental wavelength but had low reflectivity (< 5%)
for the red spectral range. The cavity configuration is shown in Fig. 4. In addition, a short-
wave pass filter was used between the folding mirror and the power head to filter out infrared
radiation leaking through the folding mirror. Whereas, a long-wave pass filter was used
between the HR cavity end-mirror and a power head to filter out the red light leaking through
the cavity end-mirror.
Fig. 4. Schematic illustration of the frequency doubled red VECSEL.
3.2 Continuous wave operation
At first, the VECSEL was operated in continuous wave mode. The cooling liquid was set to a
temperature of 1 °C, which corresponded to mount temperatures of 5–8 °C during operation.
The maximum frequency doubled output power of 10.5 W was achieved for an absorbed
pump power of 59.7 W. This corresponded to an optical-to-optical (absorbed pump power to
red output power) conversion efficiency of 17.5%. Absorbed pump power was measured by
subtracting the amount of 808 nm pump power reflected from the surface of the gain mirror.
The amount of pump radiation reflected from the gain mirror surface was 4.2%. The emission
wavelength of the VECSEL was centered at 615 nm (inset of Fig. 5) and exhibited a FWHM
linewidth of 0.4 nm. The beam profile (inset of Fig. 5) was recorded with a CCD camera
showing an elliptical shape horizontally, which might be a consequence of multi-transversal
mode operation potentially caused by the larger pump spot diameter in comparison to the
mode diameter. The output spectrum and the beam profile were recorded at 7 W of output
power. The output power curve is shown in Fig. 5.
Fig. 5. Output power curve for red emission (output power vs. absorbed pump power). Insets:
Output spectrum for red emission and lateral beam profile measured at 7 W.
The intra-cavity power of the VECSEL was determined by measuring the infrared radiation
leaking through the HR cavity end-mirror, whose transmission was determined earlier. The
intra-cavity power was then estimated by dividing the measured infrared power with the
transmission of the mirror. Furthermore, the single-pass conversion efficiency of the LBO
crystal was calculated using the measured red output power and the intra-cavity power results.
The calculation assumed that there are no losses for the red light inside the cavity, and all of
the red light escapes the cavity. At the highest output power, the intra-cavity power was
estimated to be 640 W. The maximum single-pass conversion efficiency of 0.8% was obtained
for a red output power of 9.6 W. An almost equal conversion efficiency value was obtained
for the highest red output power. Results of the intra-cavity power and single-pass conversion
efficiency calculations are shown in Fig. 6.
Fig. 6. Intra-cavity power (blue circles) and single-pass conversion efficiency (red squares) of
the nonlinear crystal (LBO) vs. absorbed pump power.
3.3 Pulsed operation
Fig. 7. Pulse waveforms for the pulsed pump laser (black trace) and the red VECSEL output
(red) recorded at maximum frequency doubled output for 1.5 µs pulse width setting.
The VECSEL was also pumped in pulsed mode. This reduces the thermal load on the chip and
leads to higher conversion efficiency. The same cavity configuration was used for the pulsed
measurements as for cw measurements except the cw 808 nm pump laser was switched to a
pulsed 808 nm pump laser. The pump laser was pulsed using a driver capable of producing
current pulses up to 1.5 µs. When the driver was set to produce 1.5 µs pulse widths, the pump
laser produced peak powers up to 70.6 W. Si-based detectors were used to record the light
pulses generated by the pump laser and the VECSEL. The pulse waveforms measured at the
maximum output power are shown in Fig. 7 for the pump laser and the VECSEL. The cooling
liquid of the gain mirror’s mount was set to near room temperature at 20 °C. Owing to the
decreased thermal load on the gain mirror, the mount temperature remained at 20 °C
throughout the pulsed measurements. For comparison, the VECSEL’s output power was also
measured in cw mode while the mount temperature was near 20 °C. In this case, the cooling
liquid was set to 16 °C. Fig. 8 shows the output power curves for both, the pulsed and cw
operation, as well as the VECSEL’s output spectrum. The maximum output power achieved in
cw mode was 8.0 W, whereas in pulsed mode the maximum peak output power was 13.8 W
for a pulse width of 1.16 µs. Furthermore, thermal rollover was reached for the cw operation,
whereas in pulsed mode the maximum peak output power was pump power limited. The
maximum average output power for the pulsed operation was 161 mW and the maximum
optical-to-optical conversion efficiency (absorbed peak pump power to peak output power)
was 20.4%.
Fig. 8. (a) Output power curves for continuous wave (red circles) and pulsed mode (blue
triangles) when the mount temperature was ~20 °C. (b) Output spectrum for the red VECSEL
measured at the maximum pulsed pump power.
4. Conclusions
A high-power GaInNAs VECSEL emitting at 615 nm, operating in continuous wave and
pulsed modes, has been demonstrated. The VECSEL emitted fundamental radiation in the
1230 nm range and was frequency doubled to ~615 nm via an intra-cavity nonlinear LBO
crystal. A maximum of 10.5 W was reached in cw mode with an optical-to-optical conversion
efficiency of 17.5% for a mount temperature of 8 °C. The single-pass conversion efficiency of
the LBO crystal was estimated to be 0.8%. In pulsed mode, the VECSEL generated a
maximum of 13.8 W of peak output power for pulse duration of 1.16 µs. In this case the
optical-to-optical conversion efficiency was 20.4% and the mount temperature stayed at 20 °C
throughout the measurements. The maximum peak output power in pulsed mode was pump
power limited; hence, even higher peak output powers are expected with a better pulsed pump
laser. The cw power measurements were limited by thermal rollover.
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1Abstract We report a compact high-power yellow laser
system for the treatment of cutaneous vascular lesions, such as
telangiectasia and port wine stains. The system is based on
optically-pumped vertical-external-cavity surface-emitting lasers
(VECSELs), which have emerged as an attractive alternative to
solid-state and dye lasers due to their enhanced functionality and
broad wavelength coverage. The reported system is capable of
delivering up to 8 W of output power at ~590 nm and includes a
handheld scanner for an easy delivery of light onto skin. The scan
area can be varied from a single spot (1.4-mm diameter) up to 49
spots covering an area of 1 cm2.  Additional features include
adjustable fluence (0 52 J/cm2), scan patterns (line, square,
hexagon) and pulse length (10 100 ms). The system has been
qualified for and is currently used in a clinical trial concerning
the treatment of facial telangiectasia (ClinicalTrials.gov
Identifier: NCT03472859). Preliminary results of the test are
reported indicating reduced treatment time for the yellow system
and power reserve that could lead to further increase of the area
treated in a single scan.
Index Terms Yellow lasers, VECSELs, semiconductor disk
lasers, telangiectasia, vascular lesions.
I. INTRODUCTION
ASERS have played an important part in the treatment of
vascular lesions since the 1960s when Dr. Leon Goldman
first suggested ruby lasers for the treatment of various
cutaneous disorders [1]. Carbon dioxide and argon lasers soon
followed the ruby laser and the first patients with port wine
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stains were treated with an argon laser in the 1970s [2]. Since
then, there has been significant advances in laser technology
and it is finally catching up with the needs of the dermatology
community, particularly in terms of the emission wavelength.
The treatment of vascular lesions with laser light is based on
the technique of selective photothermolysis published by
Anderson and Parrish in 1983 [3]. In the paper, they explain
how microvessels, or indeed any other target tissue, can be
selectively treated while minimizing the thermal damage to the
surrounding tissue by choosing the appropriate wavelength of
light. In the treatment of vascular lesions, the aim is to destroy
unwanted microvessels by targeting oxyhemoglobin inside the
vessels. The oxyhemoglobin absorbs the light energy
converting it to heat, which is then transferred to the vessel
wall resulting in the desired thermal damage [4]. At the same
time, the absorption by other chromophores, most notably
melanin, should be minimized in order to only selectively
target the microvessels.
Oxyhemoglobin has high absorption peaks at 418, 542 and
577 nm, as well as increased absorption in the near infrared
region above 800 nm, as seen from the solid red curve in
Figure 1. The absorption is highest around 418 nm, but this
region also has higher absorption by melanin (dotted brown
and orange curves) than the longer 542-nm and 577-nm
regions. Melanin absorption continues to decrease towards the
longer wavelengths of light, which makes longer yellow
wavelengths, such as 585 590 nm, better suited for the
treatment of deeper vessels [5]. On the other hand, the
increasing water absorption (dashed curve) above 600 nm
limits the use of infrared lasers for the treatment of vascular
lesions. Deeper penetration can also be achieved with higher
fluence, but this increases the risk of collateral damage due to
increased heating.
In addition to wavelength, the pulse duration of the laser
light should also be optimized according to the target
chromophore. The determination of the appropriate pulse
duration relies on the concept of thermal relaxation time
(TRT). TRT is the time needed for a chromophore to dissipate
half of its heat gained from the laser light and, ideally, the
pulse duration should match the TRT of the chromophore. If
the pulse is shorter than the TRT it might not produce enough
heat for effective treatment, whereas very short pulses can
VECSEL-based 590-nm laser system with 8 W
of output power for the treatment of vascular
lesions
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2cause vessel rupture that leads to visible purpura [10]. Then
again, pulses that are longer than the TRT produce excessive
heat at the target resulting in collateral damage on the
surrounding tissue. TRT depends on the size of the vessels,
being longer for larger vessels, and hence longer pulse
durations should be used for thicker vessels. For example, for
0.1 1 mm vessels the pulse duration should be in the range of
1 100 ms [11].
In summary, oxyhemoglobin inside microvessels can be
most effectively targeted by choosing the most appropriate
wavelength of light and by applying the correct pulse duration
for the targeted vessel thickness. The wavelength selection
minimizes absorption by other chromophores and the correct
pulse length assures effective treatment without subjecting the
surrounding tissue to excessive heat. These two concepts set
the targets for the laser development. The high hemoglobin
absorption peak at 577 nm would make it a tempting choice
for the treatment of cutaneous vascular lesions.  However,
currently used yellow lasers, such as pulsed dye lasers, have
opted for a longer wavelength of 585 590 nm in order to
increase the penetration depth and decrease the melanin
absorption while still maintaining high hemoglobin absorption.
In terms of fluence, the typical values used in the treatment of
vascular lesions by a yellow laser range between 5 and 20
J/cm2.
In this paper, we report on a yellow laser system based on
vertical-external-cavity surface-emitting laser (VECSEL)
technology and designed for the treatment of vascular lesions.
It offers an attractive alternative for the existing expensive and
cumbersome yellow lasers on the market. The developed laser
system can produce up to 8.6 W of continuous wave laser light
around 585-590 nm (the wavelength can also be extended to
615 nm and beyond [12]) with 10 100 ms pulses and 0 52
J/cm2 fluence in a desired pattern. The yellow light is directed
to the target with a handheld scanning device.
II. TECHNOLOGY
A. Available laser systems
Table I lists the currently available and studied vascular
lesion lasers on the market also indicating their emission
wavelength and pulse length [11,13]. The golden standard for
the treatment of vascular lesions is the pulsed dye laser. It has
been used to treat vascular lesions since 1985 and offers a
versatile solution for a variety of conditions [5]. The main
features include a typical emission wavelength of 585 or 595
nm, pulse durations in the 10 40 ms range and spot sizes
ranging from 3 mm up to about 10 mm. In addition, a dynamic
cooling device is often used in parallel to reduce discomfort
and to allow the use of higher fluence. The earlier versions of
the pulsed dye laser had a much shorter pulse duration of
~0.45 ms but a longer pulse was later employed to reduce
purpura and vessel rupture. The newer versions also employ
the so-called dual wavelength approach to target
methemoglobin [14]. The pulsed dye laser is the first laser that
has been designed according to the theory of selective
photothermolysis and therefore is not associated with severe
adverse effects [5]. However, the drawbacks include large size,
circular beam pattern, and high acquisition and annual
maintenance costs.
Other commercially available and traditional options for the
treatment of vascular lesions include the green KTP laser and
the yellow copper bromide laser. The KTP laser operates at a
shorter wavelength and therefore has a higher melanin
absorption, which leads to an increased risk of
dyspigmentation [15]. Whereas, the yellow copper bromide
laser is commonly associated with adverse side effects, such as
scarring and hypo- and hyperpigmentation [16]. In the 1980s,
the blue-green emitting argon laser (along with the ruby laser)
was the most frequently used laser to treat vascular lesions, but
since then it has been replaced with longer wavelength lasers.
Lasers emitting beyond the yellow spectral region, i.e. in the
red and near-infrared, have also been considered due to their
ability to penetrate deeper in the skin. Such lasers include the
red Alexandrite, diodes and Nd:YAG. However, they are used
only to target large vessels, deeply located in the skin.
Fig. 1.  Absorption curves for the main tissue components [6-9].
TABLE I
CURRENTLY AVAILABLE LASERS FOR THE TREATMENT OF VASCULAR LESIONS
Laser Technology Wavelength
(nm)
Pulse length
(ms)
KTP Frequency-doubled
solid-state laser
532 1 200
Copper
vapour
Metal-vapor laser 578 50 200
Pulsed Dye
Laser (PDL)
Dye laser 585, 590,
595, 600
0.45 1.5
Alexandrite Solid-state laser 755 3
Diode Semiconductor laser 800, 810,
930
1 250
Nd:YAG Solid-state laser 1064 1 100
3In addition, new types of yellow lasers are emerging in the
medical market as fully functional medical systems [17-19].
This suggests that laser technology is finally catching up with
the demands of the medical field, and it is now possible to
tailor laser features to specific medical applications, for
example, with semiconductor technology.
B. Frequency doubled VECSELs
Vertical-external-cavity surface-emitting lasers (VECSELs),
also known as Semiconductor Disk Lasers (SDLs), are surface
emitting semiconductor lasers recognized for their power
scaling abilities and excellent beam quality [20]. They
combine the most beneficial features of semiconductor and
solid-state lasers: wavelength tailoring through material
engineering and functionality enabled by external cavity
architectures. These features allow for a broad coverage of
lasing wavelengths in the infrared and, via second harmonic
generation with nonlinear crystals, in the visible and UV
spectral ranges [21,22]. For example, 20 W of yellow light
with good beam quality has been reported from a lab setup
[23]. Furthermore, by adding wavelength selective components
inside the external laser cavity, VECSELs can  be designed to
emit narrow linewidth [24] and have a wavelength tuning
range up to tens of nanometers [25]. It is also easy to produce
light pulses down to a few hundred nanoseconds from a
VECSEL by directly modulating the pump laser [26]. Even
shorter, picosecond or some hundreds of femtoseconds pulses
are possible by employing semiconductor saturable absorber
mirrors (SESAMs) [27,28].
Typically, a VECSEL is comprised of a semiconductor gain
mirror, one or more external mirrors and a pump laser (see
Fig. 2). The gain mirror itself incorporates a highly reflective
mirror (often a Distributed Bragg Reflector, DBR) and a
semiconductor gain region, and is usually grown by molecular
beam epitaxy (MBE) or Metalorganic Vapour Phase Epitaxy
(MOVPE). The gain region includes several quantum well
(QW) or quantum dot layers separated by barrier layers. The
purpose of the barrier layers is three-fold; they are used to
compensate for the strain that QWs can impose on the
structure, absorb pump light efficiently and confine the pump-
generated carriers to the specific QWs for recombination.
Lasing is achieved by optically pumping the gain mirror with a
suitable pump laser. Inexpensive, commercially available
diode lasers can often be utilized, since VECSELs have a
broad absorption range thanks to the semiconductor material
characteristics.
Optical pumping enables high power operation with circular
beam profiles, but it also induces significant heating in the
gain mirror because only a portion of it is converted into useful
photons. This heating can be detrimental to the operation of a
VECSEL; hence, thermal management is vital. To this end, a
conductive heat spreader element between the gain mirror and
a heat sink is typically employed. Diamond heat spreaders are
most commonly used due to their high thermal conductance
and wide transmission window. Several reviews have been
published on the technology and progress of VECSELs, the
most recent in 2017 providing also a comprehensive overview
on wavelength coverage, thermal management and power
capabilities [29]. We should also note that this technology has
been commercialized by Coherent, Inc. for medical
application, in particular with focus on the 577-nm wavelength
and ophthalmic photocoagulation treatments. The output
Fig. 2.  Schematic illustration of the VECSEL cavity inside the module.
Fig. 4.  Output power characteristics of the yellow VECSEL module delivered
through a multi-mode fiber with a 200 µm diameter of the core. Emission
spectrum and beam profile shown as insets.
Fig. 3.  Photo of the VECSEL module accompanied by a 20-cm long ruler.
4power of their commercial system is 3 6 W at 577 nm, while
for 590 nm it is much lower, typically below 1 W [30].
III. VECSEL-BASED YELLOW LASER SYSTEM
A. Laser Module Design and Processing
The semiconductor gain mirror used for the yellow laser
system was grown by MBE and designed to emit infrared
radiation in the 1180-nm range. The gain region incorporated
10 GaInAs QWs that were surrounded by GaAs barriers and
GaAsP strain compensation layers. It was grown on top of a
25.5-pair AlAs/GaAs DBR, which acted as one of the laser
cavity mirrors. The QWs were placed at the antinodes of the
optical standing wave to enhance the gain, and the material has
a resonant structure i.e. the standing wave profile has a node at
the semiconductor-air-interface.
A small chip (2.5 mm x 2.5 mm) was diced from the gain
structure and capillary bonded onto an intracavity diamond
heat spreader of good optical quality. The synthetic single-
crystal diamond heat spreader was used to extract the heat
generated by the optical pumping in the gain mirror. To
stabilize the temperature of the gain mirror, the diamond was
further attached to a TEC-cooled copper plate set at room
temperature. The top surface of the diamond was antireflection
coated for the 1180-nm emission and the 808-nm pump laser.
The external cavity of the VECSEL was built into a V-
shaped configuration defined by the gain mirror and two
external dielectric mirrors. The external cavity allowed for an
easy inclusion of intracavity components while still keeping
the laser module compact. It also enabled to take advantage of
the high intracavity power (typically 600 800 W) by inserting
a nonlinear crystal for converting the infrared radiation to
yellow via frequency doubling. For this purpose, a lithium
triborate (LBO) crystal was placed near the mode waist of the
cavity. In addition, a birefringent filter (BRF) was utilized to
fix the wavelength and polarization for the LBO crystal.
The gain mirror was pumped with a commercial 808-nm
diode laser. The pump light was delivered via an optical fiber
from the pump laser module and focused on the gain mirror
surface using lenses. Fig. 2 shows a schematic illustration of
the VECSEL cavity including the pump laser.
B. Laser Module Characterization
The VECSEL cavity was assembled and sealed inside an
airtight aluminum housing (with dimensions of 22 x 16 x 8
cm3), shown in Fig. 3. All the cavity components were glued
on a baseplate for a robust finish. The most critical cavity
components, such as the LBO crystal, also had their own TEC-
cooling. Dielectric mirrors were used to steer the yellow
output beam through a collimation lens and towards a fiber
port. The dielectric mirrors also act as wavelength filters to
remove residual fundamental radiation from the output beam.
In addition, a beam pick-off was placed in front of the fiber
port to direct a small portion of the output beam into a
photodiode for monitoring the output power. The collimated
output beam was then coupled into a multimode fiber with a
core diameter of 200 µm. The spectral features, listed in Table
II, were characterized using a spectrum analyzer. The system
output power as a function of the incident 808-nm pump power
is shown in Fig. 4. The maximum continuous wave output
power achieved was 8.6 W at 588 nm.
An important aspect of the device characterization is also
lifetime. Throughout the testing of the system and preliminary
clinical trials, we have accumulated more than 100 hours of
operation time without any sign of degradation of the laser
characteristics. What is also important is that similar gain
Fig. 5.  Photo of the VECSEL module (a), the touch-screen on top with
varied treatment parameters (b), and the MedArt handheld scanner (c).
TABLE II
TECHNICAL SPECIFICATIONS OF THE VECSEL-BASED YELLOW LASER SYSTEM
Technical Specifications
Basic features
Wavelength 585 ±5 nm
Power up to 8.6 W in cw
Size 64 x 26 x 60 cm3
Weight approx. 30 kg
Treatment parameters
Spot size 1.4 mm diameter
Pulse length 10 100 ms
Fluence 0 52 J/cm2
Scan patterns Line, square, hexagon
Scan area From single spot up to 1 cm2
Spot spacing Low, medium and high density
5material has been tested in a lifetime measurement system
involving multiple open-air cavities and exhibited more than
1000 continuous operation hours to date.
C. System Features
The VECSEL module was then integrated into a laser
system designed for medical applications, shown in Fig 5a.
The system includes the VECSEL module, the pump laser and
custom-built electronics. The system is turned on with a main
power switch in the back panel and a turn-key switch in the
front panel. The key switch enables the system usage and
activates a 30-second warm-up period, after which the laser is
-state and can be ramped up to a wanted power
level.
The treatment parameters are controlled using a
touch-screen on top of the system, shown in Fig. 5b. The
varied parameters are laser power and pulse length with typical
ranges of 0 7 W and 10 100 ms, respectively. These
parameters, along with the spot size of the output beam,
determine the treatment fluence, which is automatically
calculated and displayed on the touch-screen. The current
system produces a spot size of 1.4 mm in diameter allowing us
to reach treatment fluences up to 52 J/cm2, which is sufficient
for treating vascular lesions. The output beam exhibits good
beam quality and is shown as an inset in Fig.4. However, it
should be noted that compared to the pulsed dye laser, the 1.4-
mm spot size is relatively small. In our system, this
shortcoming is overcome by employing a handheld scanner,
which directs the fiber-coupled light onto skin in a pre-defined
pattern. Using such a scheme with a typical pulse duration of
25 ms (i.e. 25 ms dwell time on each treatment spot), an area
of about 1 cm2 can be covered in less than a second. In
addition, the use of a scanner also brings flexibility enabling a
diverse choice for treatment areas via programming.
The handheld scanner, shown in Fig 5c (from MedArt A/S,
Denmark) [31], has three different settings that can be varied
by pressing the buttons on the side of the scanner: scan pattern,
scan area size and spot density. The available scan patterns
include a single spot, line, square and hexagon profiles.
Compared to the pulsed dye laser, which usually provides only
circular beam spot profiles, these settings offer the user the
freedom to select the most appropriate pattern for each
situation. The scanner also includes a metallic distance piece
attached to the front of the scanner to indicate the correct
treatment distance of 27 mm. The scan patterns are listed in
Table II and illustrated in Fig. 6.
The laser is turned on by pushing the grey button next to the
touch-screen (see Fig. 5b), which then ramps up the laser to a
chosen power value. At this point, no light is yet emitted, since
the output of the laser is still blocked by a laser shutter. In this
-state, the user can still adjust all the main treatment
variables. The treatment is started by pressing the foot pedal
that is connected to the system; the foot pedal opens the laser
shutter and initiates the operation of the laser scanner. Once
the scanner has covered the predetermined treatment area, the
shutter is automatically closed. Thus, the system output is not
modulated in the transition periods when the scanner moves
from one spot to another. This is possible since the transition
time of the scanner from one spot to another is only 1 ms,
which is considerably smaller than the dwell time on each spot.
Consequently, the fluence introduced during the transition
periods is negligible when compared to the treatment fluence.
Several safety measures have been implemented to the
system in order to prevent any accidental light emission when
the system is on. These features require that the handheld
scanner and the output fiber be connected to the system before
the shutter can be opened by the foot pedal. Moreover, the
system also has to be at the target power level to enable light
emission; if the output power is not within 0.1 W of the target,
Fig. 6.  Illustrations of the handheld scanners scan patterns (courtesy of MedArt A/S).
6light is not emitted even if the foot pedal is pressed. The power
stability was also tested by measuring the output power of the
system through the handheld scanner for 15 minutes, which
corresponds to a typical treatment time (Fig. 7). The system
was set to emit ~4 W (typical treatment output power); the
corresponding standard deviation of the output power was only
2.6 mW. Finally, the system is also equipped with an interlock
that can be connected to a trigger signal which turns the laser
off if unauthorized personnel enter the treatment area.
Altogether, the air-cooled system weighs about 30 kg and is
portable. Since it has been being built in a computer housing
that stands upright (see Fig. 5a), it can be set on a table
without occupying any more space than a regular computer.
The technical specifications of the system are listed in
Table II.
IV. CLINICAL TRIALS
The yellow laser system was qualified for a clinical trial to
be used as an investigational device. The trial is a split-face
study that compares the efficacy of the yellow system and a
traditional green KTP laser in the treatment of dilated blood
vessels (telangiectasia) on the cheeks. The trial protocol was
approved by the local Ethical Committee (Tampere University
Hospital, Reg. No. R17111) and was commenced in early
2018. Preliminary results show that there is not a statistically
significant difference between the efficacies of the two lasers
assessed by the physicians. Fig. 8 shows the before and after
images of a patie . The left cheek was treated with
the KTP laser and the right cheek with the yellow system.
More than 75% clearance of telangiectasia was observed after
two treatments for this patient.
Secondary object of the trial is also to qualitatively assess
the usability of the yellow system. So far, the treating
physicians have reported that the treatments are performed
approximately five times faster with the yellow laser system
than with the KTP laser (due to the fast scanning ability), but
patients have experienced more pain with the yellow system,
presumably linked to higher absorption and heat generation.
The experienced pain limits the treatment fluence that can be
used with the yellow laser and, hence, might affect the
treatment outcome. However, this issue could be solved in the
future by adding a cooling device to the system. Different
cooling devices are already in use in similar dermatologic
lasers. Another perspective is that given the existing power
reserve, we could maintain the required fluence even with an
increased spot size. Thus the treatment time could be further
reduced by increasing the scanning area. The full scale results
of the trial will be published in a medical journal once the
study is completed and the statistical analysis has been
performed.
V. CONCLUSIONS
In this paper, we have described a yellow lasers system
designed and developed for the treatment of vascular lesions.
The system employs an intracavity frequency-doubled
VECSEL and produces up to 8.6 W of continuous wave light
at around 590 nm delivered through a multimode-fiber. The
illumination of the treatment area is done with a handheld
scanner with selectable scan patterns. The scan area can be
varied from a single spot (1.4-mm diameter) up to 49 spots
covering an area of 1 cm2.  A touch-screen system interface
allows for an easy control of the treatment parameters, such as
pulse length, adjustable in the range of 10 100 ms, and fluence
that can be tailored in the range of 0 52 J/cm2.
Finally, the efficacy of the yellow system is evaluated in a
split-face study against traditional green KTP laser to compare
their efficacy in the treatment of facial telangiectasia. The trial
is registered under ClinicalTrials.gov webpage with identifier
number NCT03472859. Preliminary results of the clinical
trials indicate that treatments can be performed approximately
five time faster with the yellow system than with the KTP laser
Fig. 8.  Before (left) and after (right) images of a patient taken with Visia
Imaging System. The left cheek (top line) was treated with the traditional
KTP laser and the right cheek (bottom line) with the VECSEL-based yellow
system. Two treatments with both lasers were performed at approximately
1-2 month interval.
Fig. 7.  Output power stability shown as a function of time. The yellow
system was set to emit ~4 W of output power and a power meter was used to
collect data for 15 minutes.
7and the available excess output power would enable even
faster treatment times if the spot size is increased.
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2ABSTRACT
Objectives: The primary objective of this study was to compare a traditional green KTP laser to a new
investigational yellow laser (PhotoLase) in the treatment of facial telangiectasia in terms of the treatment
outcomes. The secondary objective was to assess the functionality and reliability of the PhotoLase system from
the perspective of the user.
Study Design/Methods: The study was a randomized split-face double-blinded study that compared the treatment
efficacy of the 532-nm KTP laser and the investigational 585-nm PhotoLase laser. One or two treatments were
given based on the response of the first treatment. The improvement of telangiectasia was graded according to a
7-point Telangiectasia Grading Scale (TGS) by the subjects and blinded physicians. The subjects assessed the
amount of pain during the treatments using Visual Analogue Scale (VAS), and evaluated adverse effects 2–3 days
after the treatment(s) using a self-assessment form.
Results: At least 50% improvement was seen in 15/18 subjects after the first PhotoLase treatment, and a similar
result was observed for KTP, as assessed by the blinded physicians (p=0.29). In the subjects’ assessment, 7/18
subjects had at least 50% improvement after the first PhotoLase treatment, whereas at least 50% improvement
was observed for 10/18 subjects in the KTP side, the difference being significant (p=0.008). The amount of pain
was higher with PhotoLase compared to KTP (67.7 vs. 34.6, p<0.001). There was no difference in the frequency
of erythema, crusting or purpura between the devices, but more blistering and less edema were seen after
PhotoLase treatment (p<0.05). Treatment with PhotoLase was evaluated to be 4.7-fold faster than with KTP and
the PhotoLase system was more compact, narrower, lighter and easier to carry than KTP.
Conclusions: The investigational PhotoLase laser enables significantly faster treatments, but the process is
somewhat more painful than with KTP, otherwise providing a similar clinical outcome in the treatment of facial
telangiectasia.
Keywords: Telangiectasia; KTP laser; green laser; yellow laser; semiconductor disk laser technology;
comparative study
INTRODUCTION
Millions of people worldwide are affected by facial telangiectases, small dilated blood vessels with diameters
between 0.1 to 1.0 mm.  Predisposing conditions include rosacea, photodamage, topical steroid use and genetic
factors. Discomfort and psychological distress drive patients to seek help, and telangiectasia treatments are among
the most common dermatological laser procedures.1,2 Treatment of superficial vascular lesions is based on
selective photothermolysis, where the target chromophore is the intravascular oxyhaemoglobin in red blood cells.
Absorption of laser light heats the chromophore leading to vessel wall damage.  Several lasers are used for
vascular indications, but the standard lasers are yellow pulsed dye laser (585- or 595-nm) and green potassium-
titanyl-phosphate (KTP) laser (532-nm), because their wavelengths are close to the  and  absorption peaks (542
and 577 nm) of oxyhaemoglobin.3
The original PDL (577-nm) had a short pulse duration of 0.3 ms, causing frequently post-operative purpura.
Modern PDLs, such as CynergyTM (Cynosure) and VBeam® (Syneron Candela) operate at wavelengths of 585
and 595 nm, respectively, and have micropulse mode and adjustable pulse durations up to 40 ms for less purpura.2
Spot sizes in CynergyTM and VBeam® range from 3 to 12 mm. Currently available KTP devices have adjustable
pulse durations from 0.05 to 2000 ms and spot sizes from 0.2 to 12 mm. One KTP system, Aura XP (Laserscope),
can be equipped with a SmartScan scanner (Laserscope).
The safety and efficacy of PDL and KTP have been demonstrated in numerous studies, and both are suggested
as first line treatments for facial telangiectases by the European Society for Laser Dermatology. At least 50–90%
improvement can be expected after 1–3 treatments.3 For facial capillary malformations, PDL is still the gold
standard therapy4, but modern large spot size KTPs seem also effective and can be considered first line regimen.5,6
The advantage of the yellow PDL compared to the green KTP is the longer emission wavelength, enabling
deeper penetration and treatment of larger vessels. In addition, oxyhaemoglobin has higher absorption for yellow
than for green wavelengths. Yellow wavelengths also have lower melanin absorption, allowing treatment of darker
skin phototypes with lower risk of epidermal damage.2
However, the yellow PDL has some intrinsic disadvantages such as large size and high annual maintenance
costs. To address the needs of the dermatologic community a novel laser technology, namely optically pumped
semiconductor disk laser (SDL), has emerged to provide a compact and cost-effective alternative for a yellow
laser source. SDLs, also known as VECSELs (vertical external-cavity surface-emitting lasers), are recognized for
their power scaling abilities, transverse mode control and the ability to tailor the emission wavelength according
to specific application needs.7,8 With the addition of wavelength selective components and suitable laser cavity
configurations, SDLs can also be designed to emit narrow linewidth9 and have a wavelength tuning range up to
tens of nanometers.10 Light pulses down to a few hundred nanometers can be easily achieved by directly
modulating the pump laser of an SDL.11 Another pulsing method, possibly more attractive for medical
applications, is to use a continuous wave SDL as a source and guide it through a handheld scanning device capable
3of producing different pulse lengths and treatment patterns by moving the laser beam to a different spot. In this
case the pulse duration is limited by the mechanical capability rather than by the intrinsic modulation features of
the semiconductor, which are much faster.
The primary objective of this pilot study was to compare the efficacy of a yellow laser system based on SDL
technology to the traditional green KTP laser in the treatment of facial telangiectasia. This included comparing
the treatment outcome and the adverse effects caused by the treatment. The secondary objective was to assess the
functionality of the new yellow laser from the point of view of the treating investigators.
MATERIALS AND METHODS
Study Design
The study was a split-face comparative double-blinded study without a separate control group. It was designed
to enable a comparison between a traditional green laser and an investigational yellow laser. The split-face design
eliminated individual biases and the randomization eliminated possible small variations in the symmetry of the
telangiectases on the face. The double-blinded assessment eliminated subjective and objective biases of the
investigators and the subjects. The protocol was approved by the Ethics Committee of Tampere University
Hospital (Reg. No. R17111). The protocol followed the principles of the Declaration of Helsinki and its
amendments.
Devices
The study employed two different laser systems: the traditional green KTP laser (Aura XP, Laserscope) and
the investigational yellow laser called PhotoLase. The KTP laser emits 532-nm radiation up to 15 W, and was
equipped with a Laserscope SmartScan scanner, which delivered 127 spots with a diameter of 1.0 mm, forming a
hexagon pattern and covering an area of ~1.1 cm2 in 17.5 seconds.
The PhotoLase laser (Fig. 1a) was developed at the Optoelectronics Research Centre (ORC), Tampere
University of Technology in collaboration with the French National Institute of Health and Medical Research
(INSERM). It emits 585-nm yellow radiation up to 8 W in continuous wave operation, delivered via a multimode
optical fiber with a diameter of 200 µm. The device was equipped with a MedArt scanner (Fig. 1b) capable of
delivering the laser light in different patterns (single spot, line, square, and hexagon). One scan covered an area
of ~1.0 cm2 in less than a second and included 37 spots with a diameter of 1.4 mm. The pulse duration was
adjustable in the range 10–100 ms. Only the hexagon shape (Fig. 1c) was used to enable a more accurate
comparison of the two laser systems. The pulse duration was fixed to 25 ms based on pre-clinical tests indicating
good clinical end-point. A detailed description of the system can be found in Kantola et al. 2019 (in press).
The study also employed a Canfield Visia Imaging System to assess the effectiveness of the laser treatments.
The imaging system produces high quality multi-spectral images with standardized lighting and facial positioning.
Subject inclusion and exclusion criteria
Finnish speaking volunteering adults with symmetrical facial telangiectasia, and a Fitzpatrick’s skin phototype
I–IV, were included in the study. Exclusion criteria were unbalanced chronic disease, pregnancy, lactation,
haemophilic condition, being under guardianship, alcohol or drug abuse and significant tanning less than 6 weeks
prior to the study. All volunteers gave their informed consent.
Treatment Protocol
The subjects were randomized to receive KTP treatment on one side of the face and PhotoLase on the
contralateral side. The randomization was performed in blocks of two using a web-based validated program
(Research Randomizer). The investigators T.K. and A.K. randomized and enrolled all the participants. One to two
treatments were performed at 1- to 2-month intervals depending on the recommendation of the investigators and
preferences of the subjects. Prior to the first treatment, the investigators assessed each subject and categorized the
severity of their telangiectasia into mild, moderate or severe (Fig. 2).
Treatment parameters were selected to achieve the same clinical end-point of vessel disappearance or clot
formation within the vessel. Double passes were used when needed. KTP settings were 20–30 J/cm2 at 10-ms
pulse duration and the PhotoLase settings were 5.6–8.1 J/cm2 at 25-ms pulse duration. No topical anesthesia or
cooling was used.
Efficacy Assessments
The primary endpoint of this study was the 7-point Telangiectasia Grading Scale13, which was assessed by the
subjects and the blinded investigators (T.K. and A.K.). The TGS is scored: -1 = condition worsened; 0 = no
change; 1 = some improvement (<25%); 2 = intermediate improvement (25–50%), 3 = significant improvement
(50–75%); 4 = very significant improvement (>75%); 5 = complete resolution of telangiectasia. The investigators
assessed the TGS using the Visia images taken prior and 1–2 months after the treatment(s). The assessment was
4performed as a consensus assessment by the investigators T.K. and A.K. Even though T.K. and A.K. also
performed the treatments, the efficacy assessments can be regarded blinded, since the Visia images did not show
information about which device was used in either side of the face. In addition, the subjects gave their own best
assessment of the clinical outcome using a mirror.
Safety Assessments
Assessment of adverse effects was conducted 48–72 hours after the treatment(s) through a self-assessment
form given to the subjects. Visual Analogue Scale (VAS, 0–100) was used for pain and a 4-point scale (0=absent,
1=mild, 2=moderate, 3=severe) for erythema, edema, crusting, purpura and blisters.
Sample Size Calculation
The sample size calculation assumes, that a clinically important difference, as measured by a 7-point
Telangiectasia Grading Scale (-1–5), is 2. With an alpha error of 0.05, power of 0.80 and a sigma value of 2, we
arrived at a sample size of 16 with a sample size calculator comparing two independent samples13. Assuming that
there will be a few dropouts during the study, a sample size of 20–30 subjects is warranted.
Statistical Analysis
Statistical comparisons between the KTP and PhotoLase treatments were made using the McNemar test, Wilcoxon
signed ranks test and permutation test with exact p-values. Stata 15.1 (StataCorp LP; College Station, Texas,
USA) statistical package was used for the analysis.
RESULTS
General
Twenty-four subjects participated and completed the study. Six subjects were excluded from the analysis,
since their telangiectases were not assessable using the Visia images. The mean age of the subjects was 48 years
(range 27–63 years), sixteen (89%) females and two (11%) males. Nine subjects received KTP on the left cheek
and PhotoLase on the right cheek, and nine subjects vice versa. Five subjects (28%) received a single treatment
and thirteen subjects (72%) received two treatments. The Fitzpatrick’s skin phototypes were I, II or III in 6/8/4
subjects, respectively. The baseline telangiectasia grades were I, II, or III in 4/9/5 subjects, respectively, and the
grades were symmetrical in all of the subjects.
Safety
The amount of pain, as measured using VAS, was higher with PhotoLase when compared to KTP, 67.7 (SD 22.9)
vs. 34.6 (SD 16.9), respectively. There was no difference in the frequency of erythema, crusting or purpura
between KTP and PhotoLase, as assessed using a 0–3 scale, 2–3 days after the treatments. More blistering and
less edema were seen after PhotoLase treatment (p < 0.05, Table 1). A small superficial atrophic scar was noted
in two subjects on the PhotoLase side.
Efficacy
In the blinded investigators’ assessment, fifteen subjects (83%) had a TGS value of 3 or larger, indicating at least
50% improvement after the first PhotoLase treatment, and a similar result was observed for KTP (p=0.29). In the
subjects’ assessment, seven subjects (39%) had at least 50% improvement after the first PhotoLase treatment,
whereas at least 50% improvement was observed for ten subjects (56%) in the KTP side, the difference being
significant (p=0.008).
The potential benefit of the optional second treatment was also assessed by the subjects and the blinded
investigators. Based on the subjects’ assessment, 11/13 benefited from the second KTP treatment, and 10/13 from
the second PhotoLase treatment. The difference between the devices was insignificant (p=0.54). Based on the
blinded investigators’ consensus assessment, 9/13 subjects benefited from the second KTP treatment, and 8/13
from the second PhotoLase treatment. The difference between the devices was insignificant (p=0.81).
Figs. 3 and 4 show the before and after Visia images of a female subject with moderate telangiectasia.
Photographs were taken before and after the treatments. The left side was treated with KTP and the right side with
PhotoLase. In this case, the improvement in TGS was 4 on the KTP side and 3 on the Photolase side after the first
treatment and 4 on both sides after the second treatment.
Functionality of the investigational device
The secondary objective of the study was to assess the functionality of the investigational device. The
evaluation was performed by the investigators (T.K. and A.K.) based on their user-experience during the study.
The most obvious difference in functionality was observed in the scanning speeds of the scanners, 17.5 seconds
per 1.1 cm2 for the SmartScan scanner (KTP) and less than one second per 1.0 cm2 for the MedArt scanner
5(PhotoLase). Assuming a mean of three seconds between the scans, this yields a 4.7-fold difference in treatment
speed favouring PhotoLase. The SmartScan scanner was also larger, bulkier and heavier. The button that was
pressed to initiate the scanning was integrated to the SmartScan scanner, but the MedArt scanner was used with
a foot pedal. The investigators favored the hand-button for easier administration of the pulses. The investigational
device PhotoLase appeared to be more compact, narrower, lighter and easier to carry compared to the KTP laser.
Both laser systems were stable during the trial period and no malfunctions were noted.
DISCUSSION
To our knowledge, this is the first head-to-head study to compare a 585-nm yellow SDL to a traditional 532-
nm green KTP laser in the treatment of facial telangiectasia. We were able to recruit the desired number of subjects
with full compliance throughout the study period, and both laser systems were shown similarly effective.
Recently Kapicioglu et al. (2018) reported a non-controlled case series using a 577-nm yellow SDL for the
treatment of erythematotelangiectatic rosacea, facial erythema and facial telangiectasia. They achieved over 80%
cure rate for facial erythema and telangiectasia in 76.6% of subjects after first treatment, whereas we achieved
over 50% cure rate in 83.3% of cheeks treated with PhotoLase or KTP. Our parameters for KTP were 20–30 J/cm2
at 10-ms pulse duration and for PhotoLase 5.6–8.1 J/cm2 at 25-ms pulse duration. In comparison, Kapiciogly et
al. used 16–22 J/cm2 fluences with the 577-nm laser. There are probably two main reasons for the cure rate
difference. Firstly, our trial was conducted in private sector, where typically milder presentations of telangiectasia
are treated, compared to hospital conditions. Only 28% of our subjects had severe telangiectasia. Secondly, we
chose not to use topical anesthesia or cooling to prevent possible vasoconstriction in the treatment area, which
resulted in limitation to use higher PhotoLase fluences due to pain.
Another split-face study by Uebelhoer et al. (2007) compared KTP (Gemini, Laserscope) and 595-nm PDL
(VBeam®) for facial telangiectases. The PDL settings were a 10-mm spot, a fluence of 7.5 J/cm2, a 10-ms pulse
duration, optional pulse stacking, and dynamic nitrogen cooling spray. The KTP settings were mostly 10 J/cm2 at
18 ms and 9 J/cm2 at 23 ms with 5- and 10-mm spot sizes, respectively, and a sapphire contact cooling. The
percentage of improvement was 62% with KTP, and 49% with PDL after the first treatment, being slightly lower
than cure rates in our study. Tanghetti et al. (2012) used a 595-nm PDL (V-Star®, Cynosure) for facial
telangiectases with Zimmer air cooling and could use fluences as high as 8.1–14.5 J/cm2 with 10- and 40-ms pulse
durations. In their study, about 80% of subjects reached a 50% or higher cure rate with 1–2 treatments, a result
that we reported after the first treatment with PhotoLase.
Like the yellow SDLs, modern large spot size KTPs can challenge the gold standard role of PDLs, as shown
by Uebelhoer et al. More recently, Kwiek et al. (2017, 2018) showed the efficacy of large spot size KTP (ExcelV®,
Cutera) in patients with facial capillary malformations. The settings were a 5- to 10-mm spot size, a fluence of 8–
11.5 J/cm2 and pulse duration 4 to 9 ms. An integrated sapphire glass contact cooling was used. The median
improvement was 70.4% after a mean of 7.1 treatments in previously non-treated patients5, and 59.1% after a
mean of 6.2 treatments in previously treated patients6.
No serious side effects were reported during the present study. More blistering, but less edema was observed
for the PhotoLase system compared to KTP. A small superficial atrophic scar resulting from a blister was noted
in the PhotoLase side in two subjects, which is an unwanted adverse effect that we want to eliminate in the future.
Instead of a fixed pulse duration, we will tailor the pulse duration for the vessel caliber in the future. In addition,
epidermal cooling will be included to prevent epidermal damage and to optimize treatment parameters. We are
planning to use either an updated scanner with an integrated contact cooling, or air cooling in our future trials.
The 4.7-fold faster treatment time using the MedArt scanner can be considered a major benefit compared to
SmartScan scanner. The power reserve of PhotoLase also makes it possible to increase the scanning area of one
illumination sequence while still applying sufficient fluence on the treatment area. This would further reduce the
time of treatment, especially for larger treatment areas. We acknowledge that the present study would be stronger,
if the PhotoLase system was compared to a modern PDL or large spot size KTP. The functionality and speed of
modern devices are on a different level than that of Aura XP with SmartScan. Newer KTP devices with large spot
size can also treat telangiectases with lower fluencies due to deeper penetration and even distribution of energy,
reducing the cooling effect of blood flow.6 On the other hand, we still consider it fair to compare the clinical
outcome of the present devices, since the scanning patterns were similar and the spots sizes were close to each
other in terms of diameter.
The strengths of the present study are the randomized split-face design, high-quality Visia images and
excellent subject compliance. Some discrepancy can be seen in the subjects’ TGS assessment compared to blinded
investigators’ consensus assessment. We believe that such a difference resulted from the insensitivity of the TGS
assessment tool, which has relatively large 25% grading steps. Subjects might easily give different curing scores,
if they notice even a slight difference in the erythema between face sides. Experienced clinicians, then again, will
not let too small differences distract the overall assessment. Also, the subjects’ assessment was based on their
6memory, whereas the blinded investigators had high-quality standard and erythema-weighted images to compare
the results very systematically.
CONCLUSION
To conclude, we demonstrated non-inferiority of the novel yellow semiconductor disk laser, PhotoLase, in the
treatment of facial telangiectasia compared to the traditional green KTP laser. A major benefit of the PhotoLase
is the significant decrease of treatment time, which could be further decreased by enlarging the scanning area for
single illumination. The PhotoLase system can also be considered more user-friendly in the present setting.
However, larger studies with optimized cooling, laser parameter tailoring, and comparison to modern PDL or
KTP devices are warranted in the future.
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TABLES AND FIGURES
Table 1. The frequency of treatment reactions of the first treatment with KTP and PhotoLase. The intensity of
the reactions was scaled: 0=absent, 1=mild, 2=moderate, 3=severe.
Adverse effect Treatment
reactions 2-3
days after KTP
treatment (%)
Treatment
reactions 2-3 days
after PhotoLase
treatment (%)
P-value
Erythema 0.87
   0 1 (6) 2 (11)
   1 7 (39) 7 (39)
   2 8 (44) 6 (33)
   3 2 (11) 3 (17)
Crusting 0.55
   0 11 (61) 9 (50)
   1 4 (22) 5 (28)
   2 3 (17) 3 (17)
   3 0 (0) 1 (6)
Edema 0.007
   0 2 (11) 3 (17)
   1 1 (6) 7 (39)
   2 5 (28) 6 (33)
   3 10 (56) 2 (11)
Purpura 0.12
   0 11 (61) 14 (78)
   1 3 (17) 3 (17)
   2 1 (6) 1 (6)
   3 1 (6) 0 (0)
Blistering 0.023
   0 15 (83) 10 (56)
   1 3 (17) 3 (17)
   2 0 (0) 3 (17)
   3 0 (0) 2 (11)
P-values calculated with Wilcoxon signed ranks test.
7Figure 1. (a) Photo of the investigational yellow laser system, namely PhotoLase. The green KTP laser is also
visible in the background. (b) Photo of the handheld scanner used to deliver the yellow laser light from
PhotoLase unit (developed by MertArt A/S, Denmark) and (c) an illustration of the hexagon pattern produced
by the MedArt scanner (courtesy of MedArt). Other patterns and sizes are also available, but this study only
utilized the hexagon to enable comparison with the KTP SmartScan.
Figure 2. Flowchart of the study.
8Figure 3. Regular Visia images of a female subject with moderate baseline telangiectasia. Photographs were
taken before and after the first and second treatments. The left side was treated with KTP laser and the right side
with PhotoLase laser. In this case, the improvement in TGS was 4 on the KTP side and 3 on the PhotoLase side
after the first treatment and 4 on both sides after the second treatment.
Figure 4. Visia erythema images before and after the first and second treatments. Note the added benefit of the
second treatment on both sides of the face.
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